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SUMMARY 
 
Over the past two decades, interventional radiology has been a fast developing field 
with great advances in technology in the diagnosing and treatment of patients. 
Interventional radiology procedures are minimally invasive and require little to no 
hospitalisation time. These procedures are fluoroscopically guided and serial runs 
are used for documentation, so they have the potential to deliver high doses to 
patients. Reports about deterministic skin reactions resulting from interventional 
radiology have become more and more prevalent from the early 1990s. Worldwide 
concern thus led to legislation for the limitation, justification and optimisation of these 
doses. Setting of diagnostic reference levels (DRLs) for these procedures is difficult, 
as they can be complex in nature and are often clinically open-ended. In the case 
where DRLs were used, they needed to be for a specific locality and had to be 
refined for the specific circumstances. Patients must be informed of the doses they 
will be receiving during diagnostic or interventional procedures before consent can 
be obtained from them. Little information on dose audits was available for South 
Africa at the time of the study, and it was decided to determine dose ranges at a 
local level. 
 
The research question of this study was: “What radiation doses do patients receive 
when undergoing vascular, diagnostic and interventional procedures in the 
interventional suites at a tertiary training hospital in the Free State?” The primary 
objective was to determine the doses and dose ranges to patients. A secondary 
objective was to identify specific high dose procedures to individual patients and to 
the population. A third objective was to investigate the factors influencing these 
doses. 
 
The data of patients who received procedures in two fluoroscopic rooms at the 
research site were documented over a three-year period. The dose area product 
(DAP) values were used to calculate skin dose. With the information gathered, dose 
ranges for frequently performed procedures were determined and specific high dose 
procedures to individuals and the population identified. Factors influencing the dose 
were also investigated. This included the relationship of the level of technology, a 
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patient’s BMI and practitioners’ level of experience on dose as the research site was 
a training facility.   
 
The results indicated that both diagnostic and interventional procedures have the 
potential to deliver high doses, as was evident with the isolated occurrences where 
the response threshold for deterministic effects was exceeded. Most of the locally 
performed procedures delivered lower or on par radiation dose, compared to values 
in the literature. Increased BMI values of patients can negatively influence doses 
received. The level of a practitioner’s experience also plays a vital role in the dose 
that the patient will receive.   
 
Specific recommendations and the implementing of a dose optimisation protocol are 
proposed to reduce and optimise doses at the research site. This dose optimisation 
programme will create greater awareness about radiation dose and effects, follow-up 
procedures and dose reduction methods amongst role-payers.  
 
Key words: interventional radiology; limitation, justification and optimisation of 
radiation dose; deterministic effects; radiation dose awareness  
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CHAPTER 1  
LITERATURE REVIEW  
 
1.1  INTRODUCTION 
 
Apart from natural background radiation, medical exposures are by far the largest 
source of exposure of ionising radiation to the population. Medical exposure 
contributes more than 95% of the dose that the global population receives from 
manmade sources (Rehani et al., 2011). Since ionising radiation has enabled great 
progress in the diagnostic, therapeutic and preventative aspects of medicine, the use 
of ionising radiation in medicine is justifiable, according to the European Commission 
(1999). Radiation protection measures to prevent unnecessarily high doses from 
medical exposure should be taken. Despite the radiation protection measures, there 
is a global concern among role-players, such as the member states of the 
International Atomic Energy Agency (IAEA), about ionising radiation dose (dose) in 
general and the consequences of this dose including biological radiation effects 
(IAEA, 2010). In this context, an adage that says “You do not know what you are 
doing unless you know what you are doing” (Giles & Murphy, 2002, p. 875) indicates 
that one does not know what dose one’s patient receives unless it is monitored. 
 
Little information regarding interventional dose levels audits in South Africa is 
currently available. The only documented data related to radiation dose audits found 
at the time of the study were doses to surgeons in theatre (Van der Merwe, 2012), 
skin doses to patients during fluoroscopically guided back pain management (Acho, 
Van der Merwe & Van der Merwe, 2009) and a dose audit for fluoroscopically guided 
procedures such as Ba-enemas (barium) (Nyathi et al., 2009).  
 
The literature search for this research study was done using search engines such as 
Google Scholar / Chrome / South Africa and Mozilla Firefox, with the following key 
search words/terms: radiation dose ranges in South Africa / fluoroscopy dose audits / 
procedures / threshold values / DRLs / deterministic effects. The websites of the 
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IAEA (http://rpop.iaea.org) and Pubmed (http://www.ncbi.nlm.nih.gov/pubmed) were 
also used in the search. 
 
The extensive necessary use of radiation in fluoroscopically guided interventions in 
South Africa begs the question: What are the dose and dose distributions in 
interventional and diagnostic vascular procedures? It was this question that 
encouraged the researcher to perform the research study presented in this 
dissertation. The research question of this study was: “What radiation doses do 
patients receive when undergoing vascular, diagnostic and interventional procedures 
in the interventional suites at a tertiary training hospital in the Free State?” 
 
1.2  LITERATURE REVIEW INFORMING THE STUDY 
 
The aim of this literature review is to provide background information for this study. A 
literature overview regarding the biological effects of radiation, the development in 
the prevention and limitation of these effects, and current issues regarding dose 
reduction related to interventional radiology will be presented in the following section.  
 
The literature review will inform the reader about the biological effects of radiation, 
what mechanisms of injury can take place at certain threshold values, what patient 
doses and mentioned effects were before the 1950’s. It will also demonstrate how 
the development of interventional radiology impacted on these doses and what 
advantages this field has to the patient. The need for prevention and justification of 
high doses and associated effects in interventional radiology is paramount which is 
evident from recent literature.  In other words the literature background will 
demonstrate where we came from, advancements in the field and where we need to 
be in order to justify and optimise radiation doses at present and in the future. 
 
1.2.1  Biological effects of radiation 
 
On 8 November 1895 Wilhelm Roentgen discovered x-rays, producing the first 
radiographic images of human anatomy. It was this discovery that led to medical 
imaging technology (Bushberg et al., 2012) – a process that still uses ionising 
radiation to produce the image. The physical interaction between radiation and tissue 
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is that radiation carries enough energy to liberate electrons from atoms or molecules, 
thereby ionising them (Ionising Radiation, 2013), and this causes chemical effects. 
When tissues are exposed to x-rays, there is a risk that this radiation can cause 
these biological effects, such as inflammatory and cell-killing effects, or that it can 
induce malignancy. The possibility of these biological effects is dose-related and only 
occurs once a response threshold value has been exceeded. During interventional 
procedures the relevant threshold value can be exceeded. The International 
Commission on Radiation Protection (ICRP) states that radiation-induced 
malignancy can occur even at low doses (ICRP, 2000). The aforementioned 
mechanisms of the biological effects of radiation injury are examples of radiation 
effects, namely deterministic and stochastic effects. 
 
Deterministic effects have a threshold of approximately 1 Gy (IAEA, 2010). 
According to a report of the fourth meeting of the steering panel of the International 
Action Plan (IAP) for the radiation protection of patients, the risks for deterministic 
effects on superficial tissues such as the skin or the lens of the eye are higher. The 
literature consulted on radiation protection indicates that radiation exposure to the 
skin of individual patients during interventional radiology is known to be greater than 
for any other radiological procedure. In some interventional procedures, skin doses 
to patients’ approach those used in cancer radiotherapy fractions, and can even 
exceed 2 Gy (ICRP, 2000). If the dose received is higher than the response 
threshold causing the effect, the severity of the effect increases as this dose 
increases. Radiation effects are normally delayed and effects of multiple procedures 
are additive. These effects will be more severe if procedures are related over a short 
period of time, e.g. in one week. According to the ICRP (2000), acute radiation doses 
delivered to tissues during a single procedure or closely spaced procedures may 
cause: (a) early transient erythema at 2 Gy; (b) main erythema reaction at 6 Gy; 
(c) temporary epilation at 3 Gy; (d) permanent epilation at 7 Gy; (e) dry 
desquamation at 14 Gy; (f) moist desquamation at 18 Gy; and (g) delayed skin 
necrosis at 12 Gy. Depending on the dose received, radiation effects can be visible 
immediately or after a few days. Delayed effects can occur up to a period of six 
months after the exposure. 
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The other mechanism of radiation injury – the stochastic effect – results in an 
increased risk of radiation-induced cancer and chromosomal effects, with resulting 
genetic effects in descendants. This effect is regarded as the principal health risk of 
long-term low-dose radiation. “Stochastic” refers to the likelihood that something will 
happen. The probability of the effect – for example cancer – occurring, increases 
with dose, rather than the severity of the effect (IAEA, 2010). The public regards 
cancer as the primary health effect from radiation exposure. Cancer can be simply 
explained as uncontrolled growth of cells: “Ordinarily, natural processes control the 
rate at which cells grow and replace themselves. They also control the body’s 
processes for repairing or replacing damaged tissue. Damage occurring at cellular or 
molecular level can disrupt the control processes, permitting the uncontrolled growth 
of cells - cancer” (Stochastic effect, 2014, http://www.epa.gov).  
 
Ionizing radiation has the power to break chemical bonds in atoms and molecules – 
it is therefore a potent carcinogen. Another stochastic effect that can take place is 
changes in DNA – the “blueprints” that ensure cell repair and replacement produces 
a perfect copy of the original cell (mutations). The body can sometimes fail to repair 
these mutations or even create mutations during repair. “The mutations can be 
teratogenic or genetic. Teratogenic mutations are caused by exposure of the foetus 
in the uterus and affect only the individual who was exposed. Genetic mutations are 
passed on to offspring” (Stochastic effect, 2014, http://www.epa.gov).  
 
In a special communication of the Image Gently Campaign, Sidhu et al. (2009) state 
that children are more sensitive to radiation. A child’s lifespan is longer, during which 
possible changes can occur due to radiation exposure. Even low radiation doses can 
result in an increased risk of cancer, as demonstrated by using the linear no-
threshold model. It is thus necessary to limit the exposure of both children and adults 
during interventional procedures, as no level of radiation can be regarded as safe.  
 
Since no level of radiation can be considered as risk-free, the above information 
relates to this study, considering that the research population varied in composition 
(paediatric to adult) and received a large range of doses.   
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1.2.2  Patient doses and biological effects during the pre-1950 period 
 
In cases where radiation injuries occurred in the beginning of the 20th century, this 
was attributed to the primitive imaging devices used after the discovery of x-rays 
(1895) and ignorance relating to radiation effects. From as early as the 1930s 
through to the 1950s, fluoroscopy was used during interventional pulmonary 
tuberculosis procedures. A patient received numerous fluoroscopic studies over an 
extended period, which resulted in high skin doses with radiation skin damage. 
These procedures resulted in increased breast doses, which caused breast cancer in 
many women. This incidence called for radiation dose management and, as a result, 
regulatory agencies were established to oversee the manufacturing of x-ray 
equipment. This regulation, as well as the advancements in technology, decreased 
the incidences of skin injuries caused by fluoroscopy (IAEA, 2010). 
 
The measuring of patients’ radiation doses commenced in the 1950s. At that time, it 
was believed that biological effects caused by ionising radiation were leukaemia and 
the induction of genetic effects (Wall & Shrimpton, 1998). 
 
1.2.3  Interventional radiology  
 
The present study investigated the doses and dose ranges for vascular procedures 
that are usually performed as interventional procedures. In this section, 
interventional procedures relevant to the study are described. Gunther, Vorwerk and 
Pfannenstie (1995, in Faulkner et al., (nd)) classified interventional radiology 
procedures as being either diagnostic or therapeutic. Another classification method 
can be according to anatomical region. Furthermore, it may be subdivided into 
vascular and non-vascular procedures. 
 
In the report of the fourth meeting of the steering panel of the IAP for the “Radiation 
Protection of Patients” there are increasing numbers of procedures which use x-rays 
to guide interventions. These interventions, while replacing a surgical procedure 
which is desirable from many points of view, include radiation exposure that has the 
potential for causing radiation injuries. Why perform these procedures if it carries the 
risk of radiation injury? Korir et al. (2012) claim that when interventional radiology is 
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compared to conventional surgery, interventional techniques do not require an 
expensive operating room, space for in-patient hospital admissions and risks 
associated with the use of general anaesthetics. Interventional radiology allows the 
biopsy of lesions that had previously been inaccessible via other available means, at 
a relatively lower cost, but with greater risks of higher dose exposure (Taylor & 
Rodesch, 1995). However, the question arises as to what exactly these procedures 
entail. Interventional procedures are defined as procedures comprising guided 
therapeutic and diagnostic interventions. Percutaneous or other access is used, and 
they are usually performed under local anaesthesia and/or sedation. Fluoroscopic 
imaging is used to localise the lesion/treatment site, monitor the procedure, and 
control and document the therapy (ICRP, 2000). Factors that can influence the 
duration and complexity of an interventional procedure are the level of difficulty to 
gain access to a vessel; the tortuosity of the vessel; the level of cooperation from the 
patient; and whether the patient has multiple pathologies. The impact of the 
complexity is the increased likelihood of longer exposure time and additional serial 
runs (Padovani & Peterzol, (nd)). 
 
1.2.4  Deterministic effects and prevention in interventional radiology 
 
From the early 1990s the reporting of radiation induced skin injuries (a deterministic 
effect) due to interventional procedures started. Interventional procedures are often 
complicated, and thus they require longer fluoroscopy times than simple diagnostic 
procedures. Rehani and Srimahachota (2011) estimated in 2011 that 1 680 skin 
injury occurrences took place per year as a world-wide result from interventional 
procedures. Other contributing factors to higher skin doses are a lack of awareness, 
monitoring or understanding of dose limits for radiation effects (Rehani & 
Srimahachota, 2011). Another concern about interventional procedures is that these 
procedures are performed more regularly than in the past and their relative numbers 
are increasing when compared to conventional radiology. These procedures also 
have the possibility of increased dose, specifically when dealing with complex cases. 
According to the final report of the IAEA, it was predicted that more complex 
fluoroscopically guided procedures will be developed and could lead to more 
procedures that result in radiation injuries. These procedures will not only increase in 
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number, but it is assumed that they will also be carried out in localities where they 
will be performed with equipment not designed for dose optimisation (IAEA, 2010). 
 
1.2.5  Documenting and management of dose  
 
The United States Food and Drug Administration (FDA) received reports of 
noteworthy skin injuries due to interventional procedures in the early 1990s. As a 
result of these reports, guidance publications were released on documenting 
radiation use (Stecker et al., 2009). The FDA public health advisory on the 
avoidance of serious x-ray-induced skin injuries to patients during fluoroscopically 
guided procedures was released in 1994, and the recording of information that 
identifies the potential for serious x-ray-induced skin injuries in the patient’s medical 
file was introduced in 1995. In collaboration with professional radiological societies 
such as the American College of Radiology (ACR), recommendations on patient 
radiation exposure in medicine were published in 2007. These recommendations 
were revised in 2008 to specifically include management of the use of radiation in 
fluoroscopically guided procedures. The guideline topics stipulated the following: (a) 
patient selection; (b) procedure performance; (c) patient monitoring; (d) appropriate 
documentation; and (e) follow-up. Stecker et al. (2009) state that it is important to 
note that interventional radiology procedures are therapeutic of nature and will thus 
require radiation administration. In other words, radiation may be used in the imaging 
and treatment process. There is a certain level of associated risk with the use of 
radiation; this risk is low compared to the benefits that the patient will receive as a 
result of procedural imaging guidance (Stecker et al., 2009).  
 
Supporting the above statement and showing the way forward, a new radiation 
exposure rule (Texas Administrative Code rule §289.227) was implemented in the 
state of Texas, with effect as of 1 May 2013. This rule includes guidelines for 
radiation reporting, training personnel and establishing dose thresholds. Healthcare 
providers that perform fluoroscopically guided interventional procedures and 
Computerised Tomography (CT) must have a radiation programme in place, which 
entails the following: Patient radiation doses on all CT and fluoroscopy examinations 
must be recorded, and radiation threshold values for these procedures must be 
established. Patients must be notified if there has been a dose threshold breach, and 
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radiation safety training must be provided to all staff performing these procedures. 
According to a department spokesperson, Christine Mann, the actual doses for each 
patient need not be calculated, but the exposure parameters should be documented 
in the patient health record. The radiation dose to the skin will be estimated from the 
data if necessary (Barnes, 2013). 
 
1.2.6  Justification of high dose procedures during interventional radiology 
 
The use of ionising radiation in medicine is justifiable, since ionising radiation has 
enabled great progress to be made in the diagnostic, therapeutic and preventative 
aspects of medicine (European Commission, 1999). 
 
Navarro, Navarro and Maia (2012) declare that interventional radiology is considered 
the radiological practice that results in the highest exposures of both patients and 
health professionals, possibly leading to the occurrence of both stochastic and 
deterministic effects. Although high radiation doses to the skin are delivered during 
diagnostic and interventional procedures, these procedures have very important 
advantages. According Navarro et al. (2012) these advantages include the fact that 
only a small surgical incision is required; the procedures are effective; recovery times 
compared to post-surgical recovery are reduced; hospitalisation time is decreased, 
which favours the minimisation of exposure to hospital infections; and costs are 
reduced. 
 
1.2.7  Setting of reference levels 
 
The ICRP and the IAEA have taken actions to monitor radiation doses and to try to 
define the amount of radiation dose expected from certain defined procedures. This 
action may be linked to the current worldwide trend towards defining dose reference 
levels (DRLs) for various diagnostic procedures, in order to give guidelines to 
clinicians and radiologists regarding what range of radiation doses could be 
expected for any particular investigation type (Trueb et al., 2005). DRLs are best 
defined for each individual centre doing radiological interventions, as disease 
patterns and equipment vary significantly between centres; thus DRLs will be 
different for each individual centre (ICRP, 2000). The IAEA (2014) defines DRLs as 
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dose levels in medical radio-diagnostic practices for typical examinations for groups 
of standard-sized patients or standard phantoms for broadly defined types of 
equipment. These levels are expected not to be exceeded for standard procedures 
when good and normal practice regarding diagnostic and technical performance is 
applied. The International Basic Safety Standards (BSS), which describes standards 
for good practice, was published in July 2014 by the IAEA. According to a report of 
the IAP for the radiation protection of patients, there must be great emphasis on the 
periodic review and appropriate adjustment of reference levels in diagnostic 
radiology and interventional procedures to optimise the dose (IAEA, 2014).  
 
Optimisation is keeping the dose “as low as reasonably achievable”; taking into 
consideration economic and social factors such as locality and body type (ICRP, 
2007). For diagnostic medical exposures, this optimisation is interpreted as being as 
low a dose as possible which is consistent with the required image quality necessary 
for obtaining the desired diagnostic information. In this context of optimisation, DRLs 
were introduced to act as a reference value and are not to be applied to individual 
exposures of individual patients. DRLs are particularly useful in those areas where a 
reduction in individual or collective doses may be achieved or where a reduction in 
absorbed dose means a relatively high reduction in risk. CT and interventional 
radiology, which require longer fluoroscopy times, are seen as high dose 
examinations (ICRP, 2007). 
 
Assessment of patient dose is a relatively straightforward procedure for simple 
radiographic examinations. In the opinion of Marshall, Chapple, and Kotre (2000) it is 
less clear whether the DRL concept is applicable to more complex examinations 
such as interventional radiology procedures. As these examinations become more 
complicated, and particularly when the outcome is a surgical intervention and not 
merely a diagnosis, there is likely to be much greater individual variation in the 
patient doses. Unavoidable complications frequently arise with the positioning of 
catheters and guide wires, and interventional procedures are usually clinically open-
ended, having to continue until the surgery is complete (Marshall, Chapple, & Kotre, 
2000). In the present study, the researcher questioned if dose ranges linked to 
interventional procedures could put patients at risk to develop dose-related injuries 
or complications.    
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1.2.8  Current status of protection in interventional studies 
 
The ICRP (1991) has developed principles and concepts regarding radiation 
protection, namely justification, optimisation and dose limitation. Radiation injuries 
have been reported in interventional procedures by some of the member states of 
the IAEA, which alarmed other countries (Rehani et al., 2011). According to the 
ICRP (2000), radiological procedures should be undertaken only when it is expected 
that patient management would be positively influenced. To ensure justification, 
awareness needs to be raised about both the risks and benefits of such procedures 
among clinicians who request them. To ensure dose optimisation and limitation, all 
possible steps must be taken to keep the radiation dose as low as reasonably 
possible (ALARP). Reay, Chapple and Kotre (2003) suggest that the undertaking of 
interventional procedures may be justified in terms of the benefits the patient, such 
as longevity and improved quality of life. The radiologist still has a duty of care to 
ensure that the relatively high exposures are kept as low as reasonably possible, or 
technically achievable, consistent with a successful clinical outcome. 
 
The IAEA also noted that individual patient doses are increasing for diagnostic 
examinations and unnecessary or inappropriate examinations are increasingly being 
requested. In realising this concern the IAEA established an International Action Plan 
in 2002. The most important aspects of this plan were the development of 
standardised training material in the form of PowerPoint presentations, guidance 
documents, a number of publications and a website (http://rpop.iaea.org). This plan 
led to a series of actions in member states that showed a positive influence on 
patient radiation protection (Rehani et al., 2011). 
 
According to the ICRP (2000), many patients are not made aware of the risks of 
radiation injury or followed up to detect the onset of injury, when radiation doses from 
difficult procedures may lead to such injury. The patient has the right to be informed 
of the possibilities of such injuries and given the opportunity to decide whether the 
procedure should be performed – known as informed consent (ICRP, 2000). It is 
stipulated in the Code of Ethics of the International Society of Radiographers and 
Radiological Technologists (ISRRT) (ISRRT Version 07062010/ppr) that 
“patients/clients/relatives [must be] provided with the necessary information, 
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including radiation dose, to enable them to make informed decisions about their 
examinations and treatment, encouraging their full participation in treatment 
decisions and goals” (http://www.isrrt.org). 
 
The ideal situation is that patients should be informed of these risks when they will 
be exposed to an interventional procedure associated with a high radiation dose that 
carries a significant risk of a radiation injury. Furthermore, patients need to be 
counselled by the radiologist after the procedure on the radiation dose received, as 
well as the possible radiation risks. In order to obtain informed consent from and 
explain possible risks to a patient, it is necessary to consider and present to the 
patient the anticipated dose from the interventional procedures. It would be 
necessary to discuss the two additional radiation risks during patient imaging and/or 
treatment, namely deterministic and stochastic effects. It is therefore important to 
identify those procedures with a risk of radiation injury in order to facilitate informed 
consent. 
 
The Bonn Call-for-Action was a specific outcome during the “International 
Conference on Radiation Protection in Medicine: Setting the Scene for the Next 
Decade” held in Bonn, Germany, December 2012 by the IAEA. This was a joint 
Position Statement of the IAEA and World Health Organisation (WHO) released 
earlier in 2013. “The aims of the Bonn Call-for-Action are to: a) strengthen the 
radiation protection of patients and health workers overall; b) attain the highest 
benefit with the least possible risk to all patients by the safe and appropriate use of 
ionising radiation in medicine; c) aid the full integration of radiation protection into 
health care systems; d) help improve the benefit/risk-dialogue with patients and the 
public; and e) enhance the safety and quality of radiological procedures in medicine” 
(http://rpop.iaea.org). 
 
1.2.9  Patient dose management 
 
The Society of Interventional Radiology (SIR) released “Guidelines for Patient 
Radiation Dose Management” (Stecker et al., 2009), to be used for radiation dose 
management linked with interventional radiological procedures. A summarised 
version of a combination of the work of Stecker et al. (2009) and Vañó et al. (2013) is 
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given below, i.e. pre-procedural planning; intra-procedural management and post 
procedural care are outlined in the following section. 
 
1.2.10  Pre-procedural planning 
 
Individual training: The radiographer is responsible for being knowledgeable about 
dose levels. Initial training needs to take place in patient radiation management for 
all personnel working in the interventional radiology suite (e.g. nurses and 
radiographers). Refresher training in radiation management (institutional policies and 
government regulations) must be repeated annually. 
 
Informed consent: A patient or, in the case of a minor, the parents or legal guardian, 
should be informed of possible radiation risks, especially if the expected radiation 
dose is high. Clear and unambiguous language is to be included in the consent form, 
and “it is more than just a signed document, it is an active process between the 
physician and patient” (Stecker et al., 2009, p. 268). Previous radiation exposure 
should be taken into account during the planning process of the procedure. 
 
Procedure planning: All pre-procedure imaging and, if possible, these images, must 
be reviewed instead of reviewing reports only. These images may help in reducing 
procedure time; reducing fluoroscopy time and the amount of fluoroscopic images 
needed, and lowering the overall complication rates of the specific procedure. Non-
invasive cross-sectional imaging modalities (such as magnetic resonance imaging 
(MRI) and ultrasonography) can be used as part of the planning process regarding 
access routes and device choices. 
 
Patient’s BMI (body mass index): Weigh and measure all able patients for diagnostic 
interventional procedures to determine their BMI value. This step will indicate of how 
complex the procedure might be. It has also been shown that increased patient BMI 
values result in increased patient doses (IAEA, 2010). 
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1.2.11  Intra-procedural management 
 
Procedural radiation monitoring: The onus for dose monitoring during the procedure 
normally falls on the radiographer (technologist). Table 1.1 will assist the 
radiographer with dose monitoring during procedures. 
 
Table 1.1 Summary of radiation monitoring dose notification thresholds 
(Stecker et al., 2009, p. 269) 
Parameter First notification Subsequent 
notifications 
Peak skin dose (PSD) 2 000 mGy 500 mGy 
Reference point air kerma (Ka,r) 3 000 mGy 1 000 mGy 
Kerma-area-product (PKA) 300 Gy.cm²* 100 Gy.cm² 
Fluoroscopy time (FT) 30 min 15 min 
*Assuming a 100 cm² field at the patient’s skin. The value should be adjusted to the 
actual procedural field size. 
mGy=milli-Gray; Gy.cm²=Gray centimetres squared; min=minutes; cm²=centimetres squared 
 
The intention of this table is to enable the radiographer to assist the practitioner, 
performing the procedure, in monitoring of the radiation dose throughout the 
procedure. The radiographer will notify the practitioner when the peak skin dose 
’’reaches 2 000 mGy, then every 500 mGy after that”. The radiographer will notify the 
practitioner of the ‘’reference point air kerma initially at 3 000 mGy and then every 
1 000 mGy thereafter’’. In the case that a unit can only monitor fluoroscopy time, the 
practitioner will be notified when the ‘’total fluoroscopy time has reached 30 minutes 
and then in increments of 15 minutes or less’’ (Stecker et al., 2009, p. 269). 
 
There are varied viewpoints available in the literature on threshold values and what 
dose measure should be used to evaluate deterministic risk. The widely accepted 
threshold value for transient erythema is 2 Gy (ICRP, 2000) and although individual 
sensitivities of patients can vary, Waite and Fitzgerald suggested as early as 2001 
that entrance skin doses (ESD) greater than 1Gy should be recorded. According to 
the IAEA (2007) the air-kerma-product is a more accurate indicator of risk than ESD, 
as air-kerma-product is a product of entrance skin dose and field size. In the study of 
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Urairat et al. (2011) the displayed air-kerma-product was converted and used to 
determine a concerned level of deterministic risk of 2 Gy. The Urairat et al. (2011) 
study’s resultant correlation factors (R2) between deterministic risk and air-kerma-
products ranged from 0.69 to 0.98. The authors concluded that the air-kerma-product 
meter can be utilised as a monitoring tool for early transient erythema or epilation. 
Rehani and Srimahachota (2011, p. 9), on the other hand, discourage compliance to 
any dose effect table and state that “doses are not rigid boundaries”. Skin dosimetry 
is not likely to have accuracies of more than ±50%. The National Cancer Institute 
(NCI) suggested bands of doses for single site acute skin dose and skin reaction 
grade: “A1 (0-2 Gy) no Grade; A2 (2-5 Gy) Grade 1; B (5-10 Gy) Grade 1-2 C (10-
15 Gy) Grades 2-3 and D (.15 Gy) Grades 3-4’’ (Rehani & Srimahachota 2011, p. 9). 
 
The interventionist performing the procedure should take into consideration the 
radiation dose that the patient has already received as well as the dose needed to 
complete the procedure.  Keeping the risk-benefit ratio for the patient in mind at all 
times (although it is unlikely that a procedure will solely be stopped for breaching 
radiation thresholds), the dose of any additional procedures in the following 60 days 
should be monitored closely.  The dose of subsequent procedures will be added to 
the dose that has already been received.  Bi-plane units’ doses should be evaluated 
individually if the fields do not overlap, but should be added if they do. 
 
Dose minimisation techniques: Vañó et al. (2013) suggest a dose optimising 
programme as follows: 
 
Always use the lowest pulse rate fluoroscopy mode where possible. The low dose 
rate selected still needs to deliver adequate images for diagnostic purposes. Limit 
the fluoroscopy time and limit the number of digital subtraction angiography (DSA) 
frames and runs to the minimum, while “still achieving the clinical goals of the 
procedure” (Stecker et al., 2009, p. 269). If selecting high frame rates, this needs to 
be justified for procedures with high-flow dynamics (Kloeckner et al., 2012). Use the 
“frame grab” option whenever possible for some of the fluoroscopy images, and 
store fluoroscopic scenes (films) for documentation. Pitton et al. (2012) claim that 
only 30% of the total DAPs are a result fluoroscopy, while the other 70%, is from 
DSA frame series typically used for documenting the procedure. The total radiation 
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dose may be substantially lowered by storing fluoroscopic scenes rather than 
performing DSA frames. Collimate to the area of interest using virtual collimation. 
Keep the image detector as close to patients as possible and the x-ray tube as far as 
possible from the patient’s skin. This gap can be minimised by elevating the table 
(Pitton et al., 2012). Use magnification options sparingly. The zoom function should 
be used only if clinically essential. “C-arm angles should be varied from time to time 
if this does not interfere with the conduct of the clinical procedure, in order to 
minimise skin dose” (Stecker et al., 2009, p. 269). 
 
1.2.12  Post procedural care 
 
As part of a quality control programme, interventional radiology units must evaluate 
and record patient radiation doses. Criteria must be set to include patients for follow-
up when dosimetric limits have been exceeded. 
 
Dose documentation: Record all patient and procedure data correctly to ensure 
accurate information, which can be used for dose calculation purposes. Evaluate and 
analyse patients’ DAP values. This evaluation must be done immediately after 
completion of the procedure for all procedures involving fluoroscopy. Determine 
whether the patient will require a follow-up and inform the radiologist. The radiologist 
will schedule a follow-up with the patient’s referring clinician. This documentation 
allows for transparency and inspires confidence, especially to the patient and 
referring clinician (Kloeckner et al., 2012).   
 
The guidelines stipulated by the SIR must be followed in the dose-recording process. 
The peak skin dose and kerma-air-product must be recorded, as this acts as an 
indicator for biological effects. Comparing a patient’s dose to the table from the SIR 
guidelines will help in determining if a patient requires follow-up. “These values are 
meant to trigger a follow-up for a dose that may result in a minor reaction in an 
average patient” (Stecker et al., 2009, p. 270). If the patient’s peak skin dose 
reaches 2 000 mGy, kerma-air-product exceeds 500 Gy.cm² or the fluoroscopy time 
exceeds 60 minutes it indicates a follow-up is required. Fluoroscopic time alone is 
not a good indicator of dose received, but can be indicative of a significant radiation 
dose. 
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Patient follow-up: All patients who received dose values that reached the threshold 
value for deterministic effects are to be followed up. This does not imply that dose 
values beneath the threshold values are safe, but it is probable that doses higher 
than the threshold value will cause radiation injuries. Follow-up is recommended 
even if the dose values were lower, but the same anatomical site received radiation 
recently. A patient who has received a noteworthy amount of radiation will be given 
clear instructions for self-examination of the irradiated area. If skin changes have 
occurred, the patient will have to inform the physician who performed the procedure 
or the referring doctor. A medical physicist will evaluate the dosimetric aspects. 
 
1.2.13  Dose and image quality assessment  
 
A periodical statistical report of dose recording and dose utilisation is required. All 
procedures that have reached or exceeded the threshold values should be reported 
to the radiation control officer. Annual assessment of image quality versus radiation 
dose must form part of a complete quality control programme by an in-house medical 
physicist. 
 
1.2.14  Remaining challenges in interventional radiology 
 
According to Wall (2001), hospitals performing high numbers of angiographic and/or 
interventional procedures should develop DRLs for the more common interventional 
procedures, as the distribution and complexity is dependent on individual 
circumstances. During this study, a wide distribution (ethnic composition) of patients 
was observed; it was said that these values (DRLs) should be specific to a 
country/region. What this means is that a centre cannot adopt prescribed DRLs of 
another centre as is, and that a certain level of refining of these values has to take 
place to make it applicable for their unique circumstances and patient specifics. 
 
In the South African context, as mentioned, a study was done at the Charlotte 
Maxeke Johannesburg Academic Hospital, during the period August 2007 to March 
2008. This retrospective study was aimed at dose optimisation for fluoroscopic 
procedures, radiation doses delivered to patients undergoing fluoroscopy 
examinations in terms of the skin dose, and the dose-area product (DAP). These 
17 
procedures included fluoroscopy examinations such as Ba-enemas, only (Nyathi et 
al., 2009). 
 
Most fluoroscopic equipment delivers “surrogate measures” for skin dose only 
(Dauer et al., 2009). A prescribed methodology for evaluating skin doses to patients 
during interventional procedures is crucial. It is also suggested that trigger levels 
requiring clinical follow-up be developed. In a recent study by Jones, Ensor and 
Pasciak (2014), the accuracy of calculating the peak skin dose (PSD) from indirect 
metrics such as reference air kerma / kerma-area-product (KAP) and direct measure 
of radio chromatic film is compared. Before this displayed reference air kerma can be 
used to calculate a surrogate measure for skin dose, the accuracy of this value 
should be verified. It was found that PSD could be determined from indirect 
measures with a better than 50% accuracy for vascular and interventional oncology 
procedures. These calculated PSD values can be used to determine if follow-up is 
required if the set trigger level has been reached or exceeded (Jones, Ensor & 
Pasciak, 2014). 
 
DAP values of patients undergoing fluoroscopic diagnostic or interventional 
procedures at the research site were measured and documented as prescribed in 
the literature. Routine calculations of skin dose determined from DAP values and 
field area was not part of the current practice at the research site. Regular dose 
audits and routine follow-up did not take place at the research site, at the time of the 
study, as is recommended and stipulated in the literature. 
 
1.3  CONCLUSION  
 
Interventional radiology is regarded as procedures that can result in high skin doses 
because of their complex nature and duration. These high skin doses could result in 
skin injuries (deterministic effects). It is important that referring clinicians, 
radiologists, radiographers and patients are aware of these potentially high doses. 
Patients receiving such doses should be informed and counselled about possible 
radiation effects in order to avoiding unnecessary radiation phobias. Routine follow-
up should be done if patients exceed response threshold values for deterministic 
effects. In optimising known high dose procedures, deterministic effects will be 
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avoided in individual patients undergoing justified but long, complex procedures 
(Wall, 2001).  
 
In this chapter, the background for the study was provided with reference to the 
literature review. The results and recommendations of this study will be of value to fill 
the gap in the shortcomings of the current information in South Africa relating to dose 
and dose ranges for interventional procedures, even if only at local level. In the next 
chapter the motivation for this study, research objectives, design and the 
methodology to address the research question are described.  
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CHAPTER 2 
OVERVIEW OF THE STUDY AND RESEARCH 
METHODOLOGY  
 
2.1  INTRODUCTION 
 
The purpose of this chapter is to describe the motivation, research question and 
methodology for this study to determine radiation doses to patients during diagnostic 
and interventional procedures. The research design, research site details, population 
sample size and the method for documenting the data are discussed. The steps that 
were taken in order to present valid and reliable research findings, the method of 
grouping of data, as well as the analyses performed are outlined. 
 
2.2  PILOT STUDY 
 
During 2007, a retrospective study with the title “Audit of Staff and Patient Doses in a 
General Vascular Laboratory” was carried out in conjunction with the Department of 
Medical Physics, for the period 1 February 2006 to 31 January 2007. The following 
data were recorded: a) date of the examination; b) patient’s unique identifier; 
c) procedure; d) DAP value; and e) screening time. A total of 1 150 diagnostic and 
interventional procedures were recorded. The findings of this study were presented 
at the 26th South African Association of Physicists in Medicine and Biology 
(SAAPMB) Congress in 2007 and showed that some of the procedures included in 
the study exceeded the response threshold value for deterministic effects of 
2 000 mGy, namely uterine artery embolization (UAE) and endoscopic vascular 
aneurysm repair (EVAR) (Appendix A). 
 
The results of the pilot study warranted further research, as some procedures 
exceeded the response threshold value of 2 000 mGy.   
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2.3  MOTIVATION  
 
It is evident from the literature review that careful attention to the radiation dose to 
patients is needed during interventional procedures. Although the DAP values of 
patients were documented at the research site, doses were not calculated.  Dose 
optimisation could only be initiated once these doses were known. 
 
The research site is a tertiary training hospital in central South Africa. In the 
diagnostic radiology department interventionists, consultant radiologists and registrar 
radiologists perform vascular procedures in two separate suites, namely the vascular 
suite and E-room. A large range of diagnostic and interventional radiology 
procedures are carried out in these vascular suites. This range includes diagnostic 
angiographic procedures, vascular interventional procedures and nonvascular 
interventional procedures. These procedures are done on most organ systems, 
including the brain, kidneys, lungs and extremities. The procedures vary significantly 
in duration (referring to fluoroscopic time in seconds) depending on their variable 
complexity.  
 
As is evident from the literature, it is rather difficult to establish specific DRLs for 
interventional procedures due to the complexity and variability of the procedures 
(European Commission, 1999). Although DAP values were documented, the 
calculation of dose values (Gy) for vascular procedures at the research site had not 
been part of departmental procedure in the past. Dose values are often easier to 
interpret as it takes the field area into consideration, and threshold values for 
radiation effects are expressed in Gy. The ideal situation is that patients need to be 
counselled on the radiation dose received, as well as the possible radiation risk.  
 
At the research site it had not been current practice to inform patients about the 
radiation dose or risks associated with the interventional procedures. Research was 
needed to determine the doses at local level. 
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2.4  RESEARCH QUESTION AND OBJECTIVES OF THE STUDY 
 
The research question of this study as previously stated was: “What radiation doses 
do patients receive when undergoing vascular, diagnostic and interventional 
procedures in the interventional suites at a tertiary training hospital in the Free 
State?” 
 
The primary objective of the study arising from this question was to determine the 
doses and dose ranges to patients. A secondary objective was to identify specific 
high dose procedures to individual patients and the population. A third objective was 
to investigate the factors influencing these doses. In addressing the objectives, these 
various aspects will be examined in subsequent separate chapters. 
 
In this study, DAP values and dose values (Gy) were found to be more achievable 
measures than determining DRLs, to be used to assess the radiation dose to the 
patients. It has been decided that determining DRLs would not be practical due to 
the large variation in duration of interventional procedures. The fact that the research 
site is a training facility means that the radiologists/interventionists performing these 
procedures have various levels of experience. DRLs must be specific to a country or 
a region (Wall & Shrimpton, 2001) and dose distribution and identifying high dose 
procedures to individuals and the population would be invaluable to the research 
site. 
 
2.4.1  Dose ranges for all diagnostic and interventional procedures 
 
The dose ranges determined provided the patients’ background information about 
the radiation dose they would expect to receive during the specific procedure. As 
already stated, informed patient consent is an essential component of medical 
practice; hence, counselling the patient (or the guardian in the case of a child) on the 
risk of a procedure is mandatory (ICRP, 2000). With this information available, the 
patient will be enabled to give meaningful informed consent for the procedure as 
they will be able to understand the risks of suffering possible radiation injuries which 
may occur in extreme cases. 
 
22 
The dose ranges determined will also serve as guidelines to radiologists, clinicians 
and radiographers at the radiology department of the hospital. These dose ranges 
will inform the professionals about the range of radiation doses that could be 
expected for any particular diagnostic or interventional investigation type. The 
referring clinician will be able to assess the advantages and disadvantages (or risks) 
of the procedure, considering the patient’s clinical history. This information will also 
allow both the radiologist and clinician to make informed decisions about the 
treatment if radiation effects were to occur, as well as the aftercare of the patient 
after a particular procedure. Based on the dose ranges determined by this study and 
presented in Chapter 3, the radiologist will be more aware of the probable incidence 
of skin injuries and/or risks of radiation-induced cancer, should the procedure be 
repeated. According to the ICRP (2000) there is a probability of inflammatory and 
cell-killing effects, including skin desquamation and ulcers. These effects are dose-
related: once the dose exceeds a significant threshold (2 Gy), skin injuries can occur 
and younger patients may face an increased risk of future cancer. The threshold 
dose for the skin is relatively high (2 Gy), but can easily be exceeded in some 
interventional procedures (ICRP, 2000). 
 
2.4.2  Identify specific high dose procedures which may require patient 
follow-up to monitor skin effects 
 
Mild skin injuries might go unnoticed if patients who received more than 2 Gy to the 
skin are not followed up (IAEA, 2010). Measures to decrease radiation doses and to 
limit radiation effects must be taken, especially for the identified procedures. 
Procedures that may require alteration of and/or recommendations to specific 
procedures that will require patient follow-up have been identified. The optimisation 
of patient doses will help identify procedures in most urgent need of further 
investigation and corrective action (Wall, 2001). Radiation effects are normally 
delayed and effects of multiple procedures are additive. These effects will be more 
severe if procedures are carried out over a short period of time, e.g. in one week. 
 
Dauer et al. (2011) indicate that although the highest radiation dose is to the skin at 
the entrance site of the radiation beam, other organs receive varying radiation doses 
from either the direct x-ray beam or scattered radiation. Organ doses are determined 
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by the Effective dose (E), introduced by the ICRP (2007), which is the tissue 
weighted sum of the equivalent doses in all specified tissues and organs of the body. 
Although E has widely been used as a stochastic risk surrogate, this tissue weighted 
factor was not used in this study as it is sometimes wrongly used to demonstrate 
exceeding of threshold values of specific organs. Effective dose has been described 
as “not useful for estimating potential for skin injury” (Rehani & Srimahachota, 2011, 
p. 9). According to the final report on Dose Optimisation in Fluoroscopically Guided 
Interventional Procedures, most radiation induced injuries can be prevented and 
doses to patients for these procedures can be lowered and optimised (IAEA, 2010). 
A comparison was done of how radiation doses calculated as part of the study relate 
to threshold values for radiation effects.  The details are presented in Chapter 3. 
 
2.4.3  Comparison of doses for similar procedures performed in the two 
different venues, namely the vascular suite and E-room (newer 
technology)  
 
Over time, radiation output and image quality of fluoroscopic equipment can change. 
Aging image intensifiers can cause fading image quality and are sometimes 
compensated for by increased dose delivery (IAEA, 2010). The radiation dose of the 
vascular suite and E-room was evaluated. In Chapter 4 a comparison is drawn 
between the similar procedures that were performed in the two fluoroscopic rooms. 
 
2.4.4  Correlation of the BMI value of the patient relates to the dose received  
 
Body mass index is the mass of an individual in kilograms divided by the square of 
the individual’s height in metres (kg/m2). Fluoroscopic dose rates are influenced by a 
patient’s body mass, as the dose output increases with increasing beam attenuation 
due to increased patient mass (IAEA, 2010). 
 
For Chapter 4, the BMI values available for patients who had been weighed and 
measured during a six month period were used to investigate how this factor relates 
to the dose received. 
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2.4.5  The relationship of the practitioner’s experience to the skin dose 
received  
 
According to the final report on Dose Optimisation in Fluoroscopically Guided 
Interventional Procedures (IAEA, 2010), the experience of interventionists is a major 
factor in dose management. It has been shown that even under well-monitored and 
controlled training conditions; there have been significant increases in the dose to 
the patient delivered by interventionists who are less skilled. 
 
The level of the practitioner’s experience and training has been used to classify them 
into three standard groups, or classes, as follows: interventionist, consultant and 
registrar (Table 5.1). The radiation dose delivered by these groups was evaluated 
and compared for similar procedures presented in Chapter 5. 
 
2.5  RESEARCH DESIGN 
 
This research study, conducted at the vascular suites of the department of diagnostic 
radiology at a tertiary hospital in the Free State was a quantitative, cross-sectional 
study. According to Katzenellenbogen, Joubert and Abdool Karim (1997), this type of 
study is usually done in assessing exposure-outcome relationships. Cross-sectional 
implies that the study involved the analysis of data collected from a population, at 
one specific point in time and aimed to provide data on the entire population included 
in the study. The scientific nature of the research study required quantitative 
research. A large amount of data was gathered and then analysed statistically. This 
allowed for very little bias. A disadvantage in quantitative research that needs to be 
noted is that researchers are trying to answer their hypothesis and can bias how they 
look at the results and which parts of the results are presented. Quantitative 
research is reproducible, if other researchers ran the analysis on the data they would 
always end up with similar results. The researcher also had more control over how 
the data was gathered. Both retrospective and prospective data capturing for 
patients undergoing vascular procedures at the vascular laboratories were 
performed. Ethical approval was obtained in May 2007; thus, for the inclusion period 
of 1 February 2006 to 31 January 2009, most of the data had been captured 
retrospectively, with some data captured prospectively. 
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2.6  INFRASTRUCTURE 
 
2.6.1  Research Site 
 
The research site is a tertiary state hospital with a public-private partnership and 
670-bed capacity. The study was conducted at the vascular suites of the department 
of diagnostic radiology in the Free State. The procedures in the vascular suite were 
performed using a Siemens Multistar 180° Multispace Swivel, and a Siemens AXIOM 
Artis with its flat panel detector was used in E-room. Both were single-plane x-ray 
systems. A Diamentor DAP meter (PTW, Freiburg, Germany) fitted to the under-
couch tube assembly was used to monitor patient doses in both rooms. 
 
2.7  RESEARCH POPULATION 
 
The target population of this study included patients who had undergone diagnostic 
and interventional vascular procedures that involved fluoroscopic x-ray exposure at 
either of the two vascular suites at the research site. This population ranged from 
new-born to geriatric patients, males and females from all ethnic groups. Similar to 
the methodology in a study conducted by Dauer et al. (2009), it must be emphasised 
that there was non-randomised allocation of patients to the doctors performing these 
procedures. There was no attempt to influence how a procedure was performed in 
respect of factors such as fluoroscopic technique and image acquisition. Thus, the 
results of this study are representative of the practice at the time of diagnostic and 
interventional procedures at the research site. A total of 3 310 patients’ data were 
captured in the database over the three-year period, of which 230 were excluded 
from the study due to missing or incomplete data. 
 
2.7.1  Sample size 
 
This study’s sample size consisted of all patients who had undergone any of the 
above procedures at either of the vascular suites at the research site during the 
inclusion period of 1 February 2006 to 31 January 2009. Table 2.1 lists the inclusion 
and exclusion criteria for patients during this study.  
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Table 2.1 Criteria for patients included and excluded in the study 
Inclusion criteria 
 
Exclusion criteria 
Patients undergoing vascular procedures 
involving fluoroscopic x-ray exposure at the 
vascular suites at the research site. 
Patients undergoing non-vascular 
procedures, such as ultrasound guided 
biopsies. 
 
Procedures included screening and/or 
exposure due to single shot images or 
exposure series. 
 
Patients who received no x-ray exposure 
during the procedure. 
Patients undergoing diagnostic and/or 
interventional procedures 
Patients for which no DAP meter reading 
was available due to user omission or 
technical difficulties (such as during a 
power failure). 
 
2.8  DATA SHEET 
 
Patient data (doses) for the three-year period for all patients undergoing a vascular 
procedure in the vascular suite and E-room were entered in a database. The 
database was designed to capture both DAP and screening times for the various 
procedures, both diagnostic and interventional. Data for all the required fields were 
collected from the patient procedure record books. 
 
A data sheet (spreadsheet) was designed in collaboration with the Department of 
Biostatistics; University of the Free State, to capture the information required in 
Microsoft Office Excel 2007 for the pilot study. The data sheet was subsequently 
revised after the pilot study. The additional information required was the patient’s 
unique identifier to the hospital; the type of the procedure; the doctor and their class 
group; E-room’s data; and the height and weight of patients during a six-month 
period. The advantage of capturing the unique identifier “UM number” was that it 
provided the opportunity to revisit the patient information for follow-up purposes. For 
dose distribution to be calculated, procedures were grouped as being either 
diagnostic or interventional (Appendix C). An error field was added to indicate the 
number of patients/procedures for which no DAP reading was found. 
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2.8.1  Documenting data 
 
The information was entered on the data sheet using the headings as shown in 
Appendix B. A numerical field was assigned to each procedure and only the number 
of the corresponding procedure was captured in the spreadsheet, e.g. 1-76 
(Appendix C). Data were collected retrospectively from 1 February 2006 to 22 May 
2007 and prospectively from 22 May 2007 to 31 January 2009. For the period 
1 February 2006 to 31 December 2007, the DAP meter readings in the vascular suite 
had to be printed at the end of each procedure and the meter reset to zero, as the 
meter was located in a separate room. It happened that at the end of some 
procedures, a slip was not printed and the DAP meter was not reset between 
patients. Those patients’ data had to be omitted. For the remaining period of 
1 January 2008 to 31 January 2009, the two DAP meter readings and screening 
times were documented by the radiographer in the procedure book, as the DAP 
meter was no longer used. The readings were displayed on a computer monitor 
upon completion of the procedure. In E-room, patients’ DAP meter reading and 
screening times were documented in a procedure book. This was also displayed on 
a computer monitor upon completion of the procedure. 
 
The aim was to analyse procedures with more than 30 entries. Procedures with less 
than 30 entries were omitted from the individual evaluation, because these data 
represent less than 1% of the total number of patients in the study. 
 
Data are presented as tables and graphs to represent the mean and maximum 
doses received (Chapter 3, section 3.3). The dose values are expressed in the SI 
unit mGy. The results are displayed in tables for diagnostic and interventional 
procedures, where some procedures were grouped as previously stated. The highest 
dose diagnostic and interventional procedures to individual patients are shown, as 
well as the highest dose diagnostic and interventional procedures to the population. 
 
2.9  DATA VALIDATION 
 
In order to present valid and reliable research findings as part of this quantitative 
research design, measures have been developed to ensure valid and reliable 
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research findings. The reliability refers to the consistency of a measure, while validity 
refers to the extent to which a questionnaire/test measures what it purports to 
measure (Muller, 2014).  
 
The regular medical physics quality assurance programme at the research site 
ensured that the DAP meter readings documented were valid and reliable, which 
included calibration of the DAP meter. As a further measure to ensure that the data 
were correctly entered, the researcher scrutinised the data. If the data did not follow 
anticipated trends, the researcher referred back to the patient records to verify and, if 
necessary, correct any suspicious data. Procedures were also given a number, 
which was then classified as either being a diagnostic or interventional procedure. A 
given number could be only diagnostic or interventional, not both. The above method 
for procedures was used as a corrective measure, verifying the data after it had been 
entered. Both Microsoft Office Excel 2007 and Microsoft Office Access 2007 were 
used to track and rectify incomplete data. 
 
2.10  ANALYSIS OF DATA 
 
Data were grouped according to examination type. Procedures were grouped before 
and during data analysis. To confirm the grouping, histograms for each individual 
procedure in a group were drawn (Figures 3.1-3.3). Based on the shape of the 
distribution of the histograms, individual procedures could be grouped as follows: 
 
The Arterial Outflow Group included trans-femoral outflow (TFO), arch of the aorta 
(aorta grams) and trans-brachial outflow (TBO) procedures. These diagnostic 
procedures are considered as similar procedures, as all measure similar functional 
parameters; the only difference is the entry site of the catheter. The access site for 
TFO and arch of the aorta is through the femoral artery and for TBO through the 
brachial artery. 
 
The Cerebral Angiogram Group included four-vessel angiogram and six-vessel 
angiogram procedures, both of which demonstrate major cerebral arteries; 
additionally, a six-vessel angiogram demonstrates the internal carotid artery uni-
/bilaterally. 
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The Embolization Group included all different types of embolization, differing by the 
anatomical site where the embolization is performed. The general access site would 
be through the femoral artery. 
 
For both grouped and ungrouped procedures, skin dose values in mGy were 
calculated taking the area (cm2) of exposed skin surface from DAP meter readings in 
cGy.cm2 of each procedure into account. “If field area in cm2 is known for a particular 
exposure (e.g. at the skin surface), then the incident accumulated air kerma in mGy 
at that point can be calculated by simply dividing the KAP measurement by the area” 
(Bushberg et al., 2012, p. 306). The following equation was used to calculate dose 
for a procedure: Dose = DAP value (cGy.cm2) / area (cm2). The result in cGy then 
has to be multiplied by 10 to give the dose value in mGy. An estimated 10% error 
may occur in the field area average field dimensions. For this study, standard field 
sizes were used per procedure (Appendix C) for the purpose of uniformity. As a 
result of this error, the results after the dose was calculated (mGy) were rounded to 
the nearest whole number. 
 
The 10 procedures that contributed the highest (maximum) dose to an individual 
patient were identified. The 10 procedures that delivered the highest collective dose 
to the population were also identified. A comparison was made between doses 
received from diagnostic and interventional vascular procedures. Dose distributions 
for each examination type were calculated from the data collected over the three-
year period. Each individual procedure was evaluated, but similar procedures were 
also grouped and evaluated. The derived statistics were confidence intervals for 
different procedures, percentiles and average values. These distributions were 
compared with documented international values according to the ICRP (2000). 
 
2.11  ETHICAL APPROVAL 
 
Ethical approval for the pilot study done during 2007 was obtained and granted for a 
period of three years commencing 22 May 2007 (ETOVS NR 66/07) (Appendix D). 
An extension of the ethical approval was requested and obtained for the current 
study, as this proved to be more extensive than the pilot study. The head of clinical 
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services of this hospital also granted permission for the study to be performed 
(Appendix E), as well as the Radiation Control Committee (Appendix F). 
 
The research project did not involve any additional cost to the patient nor additional 
radiation exposure. All patients signed a consent form for the procedure to be carried 
out. Patients who were weighed and measured signed an additional consent form, 
giving permission for this anonymous data to be used in this study (Appendix G). 
 
2.12  SIGNIFICANCE OF THE STUDY 
 
Even though interventional radiology is a fast growing field with complex 
fluoroscopically guided procedures that involve long fluoroscopy times and 
sometimes multiple runs of serial imaging, some interventionists do not acknowledge 
that skin injuries as a result of the high radiation dose received have and could 
occur. The incidence of radiation skin injuries will increase unless the causes for 
these high doses are identified and restricted (IAEA, 2010). 
 
It was thus the aim to use the results of the study to determine dose ranges at the 
research site for diagnostic and interventional procedures. Specific high dose 
procedures to individual patients and the population, that may require follow-up, will 
be identified. Factors that can influence the dose to the patient in our environment 
will be evaluated. The information (dose ranges, high dose procedures and the 
factors influencing these doses from this study will result in better informed clinicians, 
interventionists, radiographers and patients as the  
 
2.13  CONCLUSION 
 
This chapter presented an outline for the study, the research question, objectives 
and research methodology to address the research question, namely what radiation 
doses patients receive when undergoing vascular, diagnostic and interventional 
procedures in the interventional suites at a tertiary training hospital in the Free State. 
A quantitative cross-sectional study was done, which included retrospective and 
prospective data capturing for patients undergoing vascular procedures between 
1 February 2006 and 31 January 2009. In the next chapter, the determination of 
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dose ranges for diagnostic and interventional vascular procedures, as well as the 
identification of specific high dose procedures, will be examined and discussed. 
  
32 
CHAPTER 3 
DOSE DISTRIBUTION FINDINGS FOR 
DIAGNOSTIC AND INTERVENTIONAL 
PROCEDURES 
 
3.1  INTRODUCTION 
 
Interventional radiology procedures are known to deliver high skin doses due to their 
complex nature and long duration; consequently, dose audits of these procedures 
are of undeniable benefit (McParland, 1998). The dose associated with these 
procedures may result in possible skin injuries; it is thus important for referring 
clinicians, radiologists, radiographers and patients to be aware of these potentially 
high doses and long imaging times. This is becoming more important as 
interventional procedures are performed more frequently each year (Bor et al., 
2008). At the research site there was an increase of 10.6% in the number of 
interventional procedures being performed from the first to the second year, and a 
4.3% increase from the second to the third year of the study period. 
 
To place interventional procedures for this study into perspective, it is important to 
indicate the differences between diagnostic and interventional vascular procedures. 
The SIR released a global statement in 2010 regarding the importance of 
Interventional Radiology (IR) in medical care for patients, which identifies and 
explains the scope of IR worldwide (Global Statement, 2014). Diagnostic vascular 
procedures involve the interpretation of medical images to identify injury and disease 
using x-ray fluoroscopy. Examples of these procedures are cerebral angiography 
and arterial outflow studies. Interventional vascular procedures are nonsurgical 
treatments for a number of medical conditions – most commonly for vascular 
diseases or abnormalities. Examples of these treatments include angioplasty, 
thrombolysis, endarterectomy, embolization of bleeding vessels and occlusion of 
brain aneurysms. Interventional radiologists can perform these procedures under the 
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guidance of x-rays, magnetic resonance or other imaging methods, depending on 
the available technology. 
 
At the study site, these interventional procedures or treatments are performed with x-
ray fluoroscopic imaging. Because the above mentioned procedures involve a 
radiation dose to the patient, it is important to be aware of the dose received by the 
patient during these procedures. As some of these procedures can deliver high skin 
doses, it is of value to identify those procedures that may carry a risk of radiation 
injury. If personnel members were to be informed about the radiation doses 
associated with interventional procedures and took note of the potential radiation 
injuries that are associated with procedures beyond the threshold dose values, they 
would be able to answer specific questions or concerns raised by the patient. 
Personnel members would also be more aware of dose optimisation by making use 
of different techniques of radiation protection during these high dose procedures. If a 
patient is knowledgeable about the radiation dose received and the possibility of 
radiation injuries they might incur, they would be able to seek help sooner if, for 
example, skin changes were to occur. 
 
The primary objective of the study was to determine from the patient records the 
dose distribution (dose ranges) for specific diagnostic and interventional procedure 
types carried out at the vascular laboratories of a tertiary hospital in the Free State. 
DAP values were used as dose measure (See Chapter 2, section 2.3). A secondary 
objective of the study was to identify specific high dose procedures to individual 
patients and to the population. 
 
3.2 METHODOLOGY FOR DETERMINING DOSE RANGES 
 
Data were captured of patients undergoing diagnostic and interventional procedures 
which involved fluoroscopic x-ray exposure at either of the two vascular suites 
(vascular suite or E-room) at the research site during the inclusion period of 1 
February 2006 to 31 January 2009. The methodology used is discussed in Chapter 
2. Data analysis was done by determining average values, confidence intervals and 
percentile values for procedures. 
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Individual procedures were grouped so as to achieve more representative sample 
sizes during data acquisition and during data analysis. For verification of the 
groupings, histograms for individual procedures in a group were created, with the 
exception of the embolization group. Based on the shape of the distribution of the 
histograms, individual procedures could be grouped as described in Chapter 3 
(Figures 3.1-3.3). 
 
3.3 DOSE RANGES OBTAINED FOR DIAGNOSTIC AND INTERVENTIONAL 
PROCEDURES 
 
A total of 3 310 patients’ data were captured, 230 of which were excluded from 
analysis (see Chapter 2, section 2.7). The number of procedures (n values) of the 
tables may be less than this initial value, as only procedures which had 30 or more 
entries are reflected.  
 
The sequence of data presented will be: 
 Dose distribution histograms of the procedure groupings (Figure 3.1, 3.2 and 
3.3); 
 Dose distribution of examinations with 30 or more entries (Table 3.1); 
 Diagnostic and interventional procedures that delivered the 10 highest skin 
doses to individual patients (Table 3.2); 
 Histogram of the dose distribution of the renal arteriogram (Figure 3.4); 
 The 10 diagnostic and interventional procedures with the highest dose to the 
population (Table 3.3); and 
 Histogram of the 10 highest total dose diagnostic and interventional procedures 
to the population (Figure 3.5). 
 
Figure 3.1 demonstrates the dose distribution histogram of the different procedures 
of the arterial outflow group. 
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TBO=Trans-brachial outflow; TFO=Trans-femoral outflow; mGy=milli-Gray 
Figure 3.1: Dose distribution histograms of aorta grams, trans-brachial and 
trans-femoral outflow studies, indicating that grouping could be done into the 
arterial outflow group according to distribution (n=663). 
 
Figure 3.1 shows that the data are not a symmetrical (Gaussian) distribution. For this 
reason percentiles were used, namely upper (75th percentile / 3rd quartile) and lower 
(25th percentile) quartile values. The dose distribution was split into bins according to 
a specific dose range in intervals of 10 mGy. The frequency indicates the number of 
times a certain dose value was received by patients during this procedure. The most 
frequently performed procedure in this group during the study was the TFO (n=530). 
The median and 3rd quartile values are the best descriptors for highly skewed 
distributions (Vañó et al., 2013). 
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Figure 3.2 demonstrates the dose distribution histogram of the different procedures 
of the cerebral angiogram group. 
 
 
mGy=milli-Gray 
Figure 3.2: Dose distribution histograms of four- and six-vessel studies 
indicating that grouping could be done into the cerebral angiogram group 
according to distribution (n=287). 
 
The four-vessel angiogram was performed most often during the study period 
(n=257), and the highest number of procedures received skin doses between 
150 mGy to 180 mGy. This distribution can fit in with a normal distribution, as the 
mean dose received was 144 mGy. 
 
Figure 3.3 demonstrates the dose distribution of the different procedures of the 
embolization group. This group comprises 16 different procedures and the individual 
procedures are not indicated as with the other grouped procedures. The grouping 
was done to obtain a larger sample size as some of the embolization procedures are 
not performed regularly. 
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mGy=milli-Gray 
Figure 3.3: Dose distribution histogram of the grouped embolization 
procedures (n=180). 
 
The majority of these procedures received less than 200 mGy, but the embolization 
group had the highest mean value (176 mGy) of all the grouped procedures. This 
interventional procedure group was the least performed (n=180). 
 
In Table 3.1 the maximum, lower, median and upper quartile skin doses for 
diagnostic and interventional procedure types that had 30 or more entries (patients) 
are listed. These procedures are ungrouped and are listed in a descending order 
according to the maximum dose. 
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Table 3.1 Dose values (mGy) for diagnostic and interventional procedures with 
30 or more entries (n=2602) 
Individual 
Procedure 
 
D/I n Lower 
Quartile 
(25
th
 %ile) 
in mGy 
Median  
(50
th
 %ile) 
in mGy 
Upper 
Quartile 
(75
th
 %ile) 
in mGy 
Maximum 
dose 
in mGy 
Renal arteriogram D 44 77 180 262 4 165 
TFO D 530 16 28 53 2 135 
Percutaneous kidney 
stone removal 
I 74 53 106 169 833 
PTA leg/arm/renal I 38 39 113 211 659 
ERCP I 263 12 24 38 630 
Hickman line I 59 3 4 9 613 
Four-vessel 
angiogram 
D 257 106 138 173 470 
Nephrostogram/my I 70 8 25 58 458 
Embolization 
aneurysm 
I 32 70 116 199 353 
PTC follow-up I 135 4 9 17 340 
Permanent catheter I 244 2 3 6 315 
PTC I 176 12 36 86 308 
Six-vessel angiogram D 30 117 156 191 288 
Oesophageal 
dilatation 
I 390 3 5 10 243 
n=number of procedures; D=diagnostic; I=interventional; mGy=milli-Gray; %ile=percentile; PTC=Percutaneous trans-hepatic 
cholangiography; ERCP=Endoscopic retrograde cholangiopancreatography TFO=Trans-femoral outflow 
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Table 3.1 Continues 
Individual 
Procedure 
 
D/I n Lower 
Quartile 
(25
th
 %ile) 
in mGy 
Median  
(50
th
 %ile) 
in mGy 
Upper 
Quartile 
(75
th
 %ile) 
in mGy 
Maximum 
dose 
in mGy 
Permanent catheter  
Revision 
I 127 3 6 12 231 
Arch of aorta D 86 9 14 25 170 
TBO D 47 18 34 57 132 
n=number of procedures; D=diagnostic; I=interventional; mGy=milli-Gray; %ile=percentile; PTC=Percutaneous trans-hepatic 
cholangiography; ERCP=Endoscopic retrograde cholangiopancreatography TFO=Trans-femoral outflow; TBO=Trans-brachial 
outflow 
 
The procedures included in this table which had 30 or more entries, comprising six 
diagnostic and 11 interventional procedures. A renal arteriogram (diagnostic 
procedure) had the highest maximum dose to an individual patient, namely 
4 165 mGy, and a median dose of 180 mGy. The second-highest maximum dose 
occurred during a TFO (2 135 mGy) with a median dose of 28 mGy. Both these two 
procedures’ maximum dose exceeded the threshold value for deterministic effects, 
namely 2 000 mGy. The TBO (n=47) had the lowest maximum dose, namely 
132 mGy.   
 
The most frequently performed procedure was the TFO (n=530) – a diagnostic 
procedure. The six-vessel angiogram had the lowest number of examinations 
(n=30). 
 
Note that all the 75th percentile values are much lower than the maximum dose 
value. None of the 75th percentile values exceeds 265 mGy, with the highest 75th 
percentile value at 262 mGy (renal arteriogram). The Hickman line has a maximum 
skin dose value of 613 mGy, a median of 4 mGy and an upper quartile value of 
9 mGy. This reduction from maximum to upper quartile and median values is also 
true for nephrostogram/my; PTC follow-up; permanent catheter and permanent 
catheter revision; PTC; oesophageal dilatation; and arch of aorta.  
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In Table 3.2 the 10 procedures that delivered the highest maximum skin doses to the 
individual patient are listed. Four of these procedures have less than 30 entries (no. 
3, 7, 8 and 9); however, these procedures need be taken into account since they 
were linked to some of the highest skin doses to patients in the study. 
 
Table 3.2: Ranking of the 10 diagnostic and interventional procedures with the 
highest maximum dose to individual patients (n=1227) 
Rank 
for 
max 
dose 
Procedure D/I n Lower 
quartile 
(25
th
 %ile) 
in mGy 
Median 
dose 
(50
th
 
%ile) in 
mGy 
Upper 
quartile 
(75
th
 
%ile) in 
mGy 
Maximum 
dose in 
mGy 
Rank  
for 
75
th 
%ile 
1 Renal 
arteriogram 
D 44 77 180 262 4 165 3 
2 TFO D 530 16 28 53 2 135 9 
3 EVAR I 16 85 200 608 1 781 1 
4 PTA 
leg/arm/renal 
I 38 39 113 211 659 5 
5 ERCP I 263 12 24 38 630 10 
6 Four-vessel 
angiogram 
D 257 106 138 173 470 7 
7 Embolization 
kidney/renal 
I 9 153 185 326 406 2 
8 Iliac stent I 17 64 99 182 305 6 
9 Renal stent I 6 90 143 217 234 4 
10 TBO D 47 18 34 57 132 8 
n=number of procedures; D=diagnostic; I=interventional; mGy=milli-Gray; %ile=percentile; TFO=Trans-femoral outflow; 
EVAR=Endoscopic vascular aneurysm repair; PTA=Percutaneous trans-luminal angioplasty; ERCP=Endoscopic retrograde 
cholangiopancreatography; TBO=Trans-brachial outflow 
 
Procedures were ranked from 1-10 (according to the maximum skin dose). The 
maximum individual dose delivered during a procedure was 4 165 mGy for a renal 
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arteriogram, followed by a TFO at 2 135mGy and EVAR at 1 781 mGy. The 
threshold value for radiation injuries such as skin erythema (deterministic effect) is 
2 000 mGy. The mentioned procedures exceeded (4 165 mGy and 2 135 mGy) or 
approached (1 781 mGy) this threshold value. 
 
Procedures were also ranked from 1-10 for the 75th percentile value. In this column, 
an EVAR had the highest 75th percentile value of 608 mGy and an ERCP 
(endoscopic retrograde cholangiopancreatography) the lowest, namely 38 mGy. 
There is a large difference between the 608 mGy and the 57 mGy (TBO), 53 mGy 
(TFO) and 38 mGy (ERCP). It is noteworthy that none of the 75th percentile values 
for individual patients was near or even approaching threshold values for 
deterministic effects. An EVAR delivered the highest median dose of 200 mGy. A 
total of 75% of patients will receive doses in the 75th percentile range and less. For 
this reason, the 75th percentile values were also ranked from 1-10 in Table 3.2. An 
EVAR delivered the highest 75th percentile value of 608 mGy, followed by an 
embolization of renal artery/kidney at 326 mGy where, interestingly, these 
procedures ranked third to seventh for maximum dose to individual patients. A renal 
arteriogram ranked first for maximum individual dose and third in the 75th percentile 
range at 262 mGy. The TFO, a diagnostic procedure (n=530), was ranked second 
for the maximum dose (2 135 mGy) and ninth in the 75th percentile range (53 mGy). 
The reason for this difference between the upper quartile value and the maximum 
dose requires further investigation. 
 
TFO, a diagnostic procedure, was performed most frequently (n=530) during the 
study period. The procedure performed least often was the renal stent, an 
interventional procedure (n=6), which ranked ninth for the maximum dose (234 mGy) 
and fourth in the 75th percentile range (217 mGy). 
 
In Figure 3.4 the histogram of the dose distribution of the renal arteriogram 
procedures in this study is shown.  
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mGy=milli-Gray 
Figure 3.4: Dose distribution histogram of renal arteriograms 
 
From Figure 3.4 it can be seen that although the highest individual dose to an 
individual patient was delivered during a renal arteriogram (4 165 mGy), this was an 
isolated incident and resulted in the mean being much higher than expected from the 
75th percentile and the median dose values (see Table 3.3). The remaining dose 
values delivered during a renal arteriogram are significantly lower than this outlier, as 
illustrated by the median dose of 180 mGy versus the 4 165 mGy of the maximum 
dose. 
 
In Table 3.3, the procedures that delivered the 10 highest collective doses to the 
population are listed. The collective dose is the average (mean dose) multiplied by 
the number of patients, and gives an indication of the procedures with the highest 
dose to the population in the study. This is an important value for evaluating possible 
stochastic effects. The sum of average doses from the vascular suite and E-rooms 
was used for the collective dose. 
 
  
Dose Distribution Histogram 
of Renal Arteriograms 
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Table 3.3: Ranking of the 10 diagnostic and interventional procedures with the 
highest summed dose to the population (n=1527) 
Rank 
for 
sum in 
mGy 
Procedure D/I n Lower 
quartile 
(25
th
 
%ile) in 
mGy 
Median 
dose 
(50
th
 
%ile) in 
mGy 
Mean 
dose 
in 
mGy 
Upper 
quartile 
(75
th
 %ile) 
in mGy 
Sum in 
mGy 
1 Four-vessel 
angiogram 
D 257 106 138 144 173 37 025 
2 TFO D 530 16 28 45 53 23 996 
3 Renal arteriogram D 44 77 180 292 262 12 831 
4 PTC I 176 12 36 60 86 10 498 
5 ERCP I 263 12 24 38 38 9 948 
6 EVAR I 16 85 200 391 608 6 260 
7 PTA leg/arm/renal I 38 39 113 151 211 5 728 
8 Nephrostogram/my I 70 78 25 48 58 3 335 
9 TBO D 47 18 34 42 57 1 986 
10 Arch of aorta D 86 9 14 20 25 1 730 
n=number of procedures; mGy=milli-Gray; D=diagnostic; I=interventional; %ile=percentile; TFO=Trans-femoral outflow; 
PTC=Percutaneous trans-hepatic cholangiography; ERCP=Endoscopic retrograde cholangiopancreatography; 
EVAR=Endoscopic vascular aneurysm repair; PTA=Percutaneous trans-luminal angioplasty; TBO=Trans-brachial outflow 
 
From Table 3.3 the following procedures delivered the highest dose to the 
population: four-vessel angiogram (37 025 mGy), TFO (23 996 mGy), renal 
arteriogram (12 831 mGy), PTC (10 498 mGy) and ERCP (9 948 mGy). The 
collective doses of the other five procedures listed in the table were clearly lower. 
 
When comparing the ranking of maximum skin dose to individuals (Table 3.2) and 
doses to the population (Table 3.3), the following procedures delivered both high 
doses to individuals as well as the population: renal arteriogram; TFO; EVAR; four-
vessel angiogram; ERCP; and TBO. 
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Figure 3.5 demonstrates the distribution range between the collective doses of the 
top 10 procedures from the highest ranking procedure to the lowest ranking 
procedure. 
 
 
TFO=Trans-femoral outflow; PTC=Percutaneous trans-hepatic cholangiography; ERCP=Endoscopic retrograde 
cholangiopancreatography; EVAR=Endoscopic vascular aneurysm repair; PTA=Percutaneous trans-luminal angioplasty; 
TBO=Trans-brachial outflow 
Figure 3.5: Histogram of the 10 highest collective doses, diagnostic and 
interventional procedures, to the imaged population 
 
The four-vessel angiogram delivered the highest dose to the population, and the 
arch of the aorta the lowest dose. This is in keeping with the formula for collective 
dose, where the mean dose is multiplied by the number of patients. The four-vessel 
angiogram was performed third-most frequently. The TFO was performed most 
often, but had the second-highest collective dose due to the fact that the mean dose 
(45 mGy) was lower than the mean dose for four-vessel angiogram (144 mGy). The 
arch of the aorta had the lowest mean dose (20 mGy), and was performed 86 times 
during the study period.   
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Collective Dose (mGy) 
Sum in
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3.4  DISCUSSION 
 
Grouping is especially useful in the embolization category (Figure 3.3), as some of 
these procedures were not performed as frequently and had less than 30 entries per 
group. Procedures in the embolization category are known to result in a high skin 
dose to the patient due to its complexity. It was meaningful to group the embolization 
procedures in order to obtain a bigger sample size. Although these procedures were 
performed less frequently, it can be seen that they deliver a high skin dose to 
patients. 
 
From Table 3.1 it is seen that the renal arteriogram had the highest maximum dose 
to an individual patient, namely 4 165 mGy, and a TFO a dose of 2 135 mGy. Both 
these two procedures’ maximum dose exceeded the threshold value for deterministic 
effects, namely 2 000 mGy. The maximum dose delivered during an EVAR, an 
interventional procedure, was 1 781 mGy. This dose is approaching the threshold 
value for radiation injuries such as skin erythema (deterministic effect) at 2 000 mGy. 
 
In Table 3.2 the 10 procedures that delivered the highest doses to individual patients 
were listed. A renal arteriogram and TFO had doses exceeding threshold values for 
deterministic effects. An EVAR had the maximum value approaching the threshold 
value for deterministic effects. It must be stressed that the maximum skin dose 
delivered was probably a once-off occurrence (outlier) as the individual doses of the 
other procedures listed were significantly lower and did not exceed the threshold 
value for deterministic effects. The upper quartile values for the 10 procedures were 
significantly lower than the maximum values. As data were not discarded, the 
meaningful dose range would be between the 25th and 75th percentile values. This 
demonstrates where the central 50% of values lies. The most important value is the 
upper quartile value, as only 25% of all patients received more than this value 
(dose). The upper quartile value (75th percentile) is of great importance when 
obtaining informed consent from a patient. This value will give the patient an 
indication of the dose they might receive. 
 
“The collective effective dose for an individual is calculated as the sum of all 
individual effective doses over the time period being considered due to ionising 
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radiation” (http://en.wikipedia.org). The time period for this calculation was the study 
period (Chapter 2, section 2.5). Collective dose of the population is the product of the 
number of people exposed and the average dose (mean) (Kathren & Moeller (nd)). 
The number of individuals per procedure is specified in Table 3.3. This demonstrates 
that some procedures with high doses to individual patients are not performed as 
frequently, but still result in high doses to the population. It is intended that the 
values in the sum column reflect the dose delivered to the population for the sample 
we were studying and will be dependent on the number (n) of patients. As seen in 
Table 3.2, the procedure, embolization kidney/renal artery, was performed only nine 
times over the three-year period, but was ranked second in the 75th percentile value. 
 
It is reassuring that all the upper quartile values shown in Table 3.3 are significantly 
lower than the response threshold value for deterministic effects of 2 000 mGy. It is 
interesting to note that in the procedures with the top 10 maximum doses, four of the 
procedures are diagnostic procedures and six interventional procedures. The top two 
maximum dose procedures are diagnostic procedures. 
 
As mentioned earlier, establishing DRLs was not part of this study. Dose ranges for 
diagnostic and interventional procedures are rarely published and the only way to 
compare the research site values with that of values generated at other sites is by 
comparing it to documented DRL values. Table 3.4 demonstrates the maximum 
doses received at the research site compared to Swiss DRLs and DRL values from 
the literature in a paper titled “Adult Reference levels in Diagnostic and Interventional 
Radiology for Temporary Use in Switzerland” (Aroua et al., 2004). These Swiss 
DRLs were established during the 1998 nationwide dosimetric survey on exposure. 
A second survey in 2003 focused on dose-intensive fluoroscopic examinations from 
five university hospitals. Eight diagnostic and interventional examinations were 
investigated with the aim of establishing a set of provisional DRLs for diagnostic and 
interventional examinations performed in Switzerland, based on average patient 
doses. The DRLs for Switzerland and the compared DRLs from the literature 
consulted during the study of Aroua et al. (2004) were established based on average 
patient effective doses multiplied by 1.5. The DRLs obtained were rounded to the 
nearest whole number. The DRLs for the research site were calculated in the same 
way, also rounded to the nearest whole number, for comparison purposes. 
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Table 3.4 Comparison of DRLs for corresponding fluoroscopic procedures of 
the research site and Swiss values (Research site DAP=mean DAPx1.5) (Aroua 
et al., 2004, p. 293) 
Procedure D/I Switzerland 
DAP (mGy.cm²) 
Literature 
DAP (mGy.cm²) 
Research 
site 
DAP 
(mGy.cm²) 
Research 
site 75
th
 %ile 
DAP 
(mGy.cm²) 
ERCP I 220 000 19 400 44 000 39 000 
Cerebral 
angiography 
D 50 000 102 000 169 000 138 000 
Renal 
angiography 
D 160 000 139 000 -265 000 175 000 262 000 
Abdominal 
angiography 
D 90 000 92 000 109 000 
(TFO) 
53 000 
Biliary 
drainage/PTC 
I 215 000 103 000 - 184 000 70 000 86 000 
Angioplasty I 14 000 - 155 000 74 000 - 108 000 90 000 211 000 
Abdominal 
embolization 
I 478 000 123 000 277 000 
(Renal) 
326 000 
D=diagnostic; I=interventional: DAP=Dose area product; mGy.cm²=milli-Gray centimetres squared; ERCP=Endoscopic 
retrograde cholangiopancreatography; TFO=Trans-femoral outflow; PTC=Percutaneous trans-hepatic cholangiography 
 
The DRL value for ERCP at the research site is higher than the value from the 
literature (the literature column values are from the abovementioned article), but 
much lower than the Swiss values. The reason for this phenomenon can also be the 
fact that as in Switzerland, ERCPs at the research site are mainly a therapeutic 
(interventional) procedure. Being a therapeutic procedure, it requires longer 
fluoroscopy times due to the complex nature. Diagnostic ERCPs or equivalent 
examinations are currently being performed mostly by using other modalities (non-x-
ray) such as MRI (Aroua et al., 2004). 
 
The DAP values for cerebral and abdominal angiography at the research site exceed 
the DAP values for both Switzerland and values from the literature. A possible 
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explanation for these higher values at the research site will be discussed in 
Chapters 4 and 5. Since there is no clearly defined abdominal angiography group, 
the closest comparable procedure for abdominal angiography in the current study is 
the TFO group, as it not only images abdominal vessels, but also the lower 
extremities. This could also explain the higher value. Renal angiography at the 
research site’s DAP value is higher than the value for the Switzerland study, but well 
within the DAP range from the literature. Biliary drainage/PTC, angioplasty and 
abdominal embolization DAP values are lower than the Swiss DAP values and 
compare well to literature values. The lower values might be attributed to the 
interventionists performing these interventional procedures. In the mentioned study, 
there is no clearly defined abdominal embolization group; for this reason, the renal 
embolization group was used for comparison. 
 
A comparison between the doses delivered to the patients at the research site and 
reference dose values from The National Patient Dose Database (NPDD) (Hart, 
Hillier & Wall, 2009) is listed in Table 3.5. This database comprises data collected 
from 316 hospitals in the United Kingdom (UK) over a five-year period ending 2005. 
These values are based on the third quartile values of the mean patient doses. The 
doses at the research site were rounded off to the nearest whole number. These 
were the only vascular diagnostic or interventional procedures listed in the database 
that corresponded to procedures performed at the research site. 
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Table 3.5 Comparison of dose-area product (DAP) of the research site, UK and 
international values for corresponding fluoroscopic procedures (Hart, Hillier & 
Wall, 2009, p. 9) 
Procedure D/I Mean national 
reference doses for 
the UK DAP per 
exam (mGy.cm²) 
Mean DAP 
values at 
research site  
per exam 
(mGy.cm²) 
Mean DAP values at 
other European 
countries per exam 
(mGy.cm²) 
Biliary 
drainage/intervention 
I 50 000 47 000  
Hickman line I 3 000 13 000  
Nephrostomy I 14 000 37 000  
Oesophageal dilatation I 11 000 4 000  
Oesophageal stent I 25 000 13 000  
Femoral angiography D 33 000 72 000 Germany       85 000 
Switzerland 210 000 
D=diagnostic; I=interventional; DAP=Dose area product; UK=United Kingdom; mGy.cm²=milli-Gray centimetres squared  
 
At the research site all the procedures have lower DAP values, except for the 
Hickman line, nephrostomy and femoral angiography. However, when local mean 
DAP values for femoral angiography (72 000 mGy.cm²) is compared to mean DAP 
values from Germany (85 000 mGy.cm²) and Switzerland (210 000 mGy.cm²), this 
value is lower (Hart, Hillier & Wall, 2009, p. 11). 
  
50 
3.5  CONCLUSION 
 
The results of this part of the study showed that selected procedures, such as renal 
arteriogram and TFO, have exceeded the threshold value for deterministic effects 
(see Table 3.1). It is thus necessary to evaluate each patient’s dose after completion 
of the procedure to determine whether the threshold value for deterministic effects 
was approached or exceeded in order to inform the patient, radiologist and referring 
clinician about possible skin injuries. The maximum dose distributions showed that 
the two highest dose procedures were diagnostic, namely renal arteriogram and 
TFO, followed by the highest interventional dose procedure – an EVAR. 
 
The 10 highest dose procedures to individual patients and the population were 
identified (Table 3.2 and 3.3). These specific high dose procedures identified require 
optimisation. Considerations must be made to determine possible dose adjustments 
to lower these doses. In the current study renal arteriograms, TFOs, EVARs, four-
vessel angiograms and ERCPs are the procedures that delivered high doses to 
individual patients and the population. By optimising these procedures’ doses at the 
research site the greatest effect will be seen to both individual patients, but 
especially to the population, as these procedures are performed most often.   
 
It is interesting to note that the top 10 highest dose procedures to the population 
consist of five diagnostic vascular procedures and five interventional vascular 
procedures. The top three highest doses are diagnostic procedures, followed by five 
interventional procedures. This can be explained by the following calculation: 
Diagnostic procedures are performed more often (n), which results in a high 
population dose. Interventional procedures are not performed as often (n lower), but 
can deliver a high dose to the patient due to the complex nature of the procedure. 
Subsequent to the dose ranges and identification of high dose procedures in this 
chapter, further evaluation of factors that influence dose will be discussed in Chapter 
4. The fluoroscopy equipment characteristics and the BMI of the patient’s 
relationship to dose were evaluated. 
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CHAPTER 4 
FACTORS INFLUENCING FLUOROSCOPIC 
DOSE  
 
4.1  INTRODUCTION 
 
In the previous chapter, dose distribution and ranges for procedures at the research 
site were determined, and specific high dose procedures to an individual patient and 
the population were identified. This section will deal with the third objective of 
investigating the factors that influence radiation dose during diagnostic and 
interventional procedures.   
 
Factors that can influence patient fluoroscopic dose include, among others: dose and 
time; field size (area); patient size; distance and scatter; complexity of the case; skill 
of the radiologist performing the procedure; and fluoroscopy equipment 
characteristics (Molyvda-Athanasopoulu et al., 2011). Trueb et al. (2005) conducted 
a study to define the DRLs for fluoroscopic high dose procedures in Switzerland. It 
was concluded that although the frequency at which fluoroscopic x-ray examinations 
are performed is low; these procedures contribute considerably to the overall 
collective dose of medical exposure. The high doses during fluoroscopic 
interventional procedures have the potential to induce deterministic effects and the 
risk of radiation-induced cancer, a stochastic risk, can also be significant (Bleeser et 
al., 2008). In children, radiation doses will vary greatly depending on the age, 
gender, body mass, body thickness and cooperation of the child (Hiorns, Saini & 
Marsden, 2006). 
 
In a study by Bor et al. (2005), an increase in radiation dose during fluoroscopic 
procedures has been observed, as these cases become more complex. This 
increase can be attributed to the use of lateral x-ray tubes (dual plane fluoroscopy), 
long screening times, numerous radiographic frames and using electronic 
magnification (Bor et al., 2005). As previously stated (Chapter 1, section 1.2.4), 
doses from interventional procedures vary greatly due to their complexity and 
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numerous other factors, such as patient anatomy, lesion characteristics, equipment 
used and operator experience. During fluoroscopically guided interventions, the 
equipment selection and configuration cause a wide variation in the doses delivered. 
High radiation doses might be caused by suboptimal or outdated equipment or 
incorrect equipment settings (Balter et al., 2011). 
 
The primary objective of this part of the study was to evaluate the research site’s 
overall dosimetric performance during diagnostic and interventional vascular 
procedures. A comparison of doses for similar procedures performed in the two 
different venues, namely the vascular suite and E-room (newer technology), was 
done. 
 
A secondary objective of this part of the study was to demonstrate the correlation 
between the body mass index (BMI) value of the patient and how this value relates 
to the dose received.  BMI is the mass of an individual in kilograms divided by the 
square of the individual’s height in meters, given in units of kg/m2 (Body Mass Index, 
2014). Fluoroscopic dose rates are influenced by a patient’s body mass as the dose 
output increases with increasing beam attenuation due to increased patient mass 
(IAEA, 2010). BMI is a scaled measure of the relative size of the patients; the 
attenuation of the x-ray beam is possibly more reliably related to the thickness or 
mass of the patient rather than the scaled mass.  A tall person may have a BMI of 
24, but may still cause greater attenuation and will require a high entrance dose; 
thus, BMI may not always be an accurate measure to predict the dose that will be 
received. Although the method of having the beam attenuation directly related to the 
thickness of the patient may be more useful to typical practice, as mentioned the aim 
of this study was not to determine DRLs. It was decided to use the information 
available (weight and height) to determine whether there is a valid correlation 
between BMI and radiation dose received. For the purpose of this study BMI will be 
used as a measure, as the circumference of the patients was not measured. 
 
In this chapter, two of these factors are investigated, namely fluoroscopy equipment 
characteristics, and BMI’s relationship to dose. A comparison was made between 
radiation doses delivered by an image intensifier system and doses delivered by flat 
panel detector technology. The relationship between a patient’s BMI value and the 
53 
dose they received was also investigated. In Chapter 5 the relationship between the 
level of experience of the practitioner performing the procedure and the dose 
received by the patient will be investigated and discussed. This chapter will focus on 
the comparison of flat panel detector technology with an older image intensifier unit 
and the correlation of BMI’s influence on dose. 
 
4.2  ASSESSING RELATIONSHIP OF DOSE WITH LEVEL OF IMAGING 
TECHNOLOGY AND PATIENT BMI 
 
To achieve the objective, the methodology described in Chapter 2 was followed. 
Additional information collected included an indication of which room the study was 
performed in, namely the vascular suite or E-room. A comparison was made 
between the doses of a number of similar procedures and grouped procedures (as 
discussed in Chapter 3) that were performed in the two fluoroscopic rooms at the 
research site. These doses were delivered by the Siemens Multistar 180° Multispace 
Swivel in the vascular suite and the Siemens AXIOM Artis in E-room.   
 
In Table 4.1 the specifications of these two units are listed according to the 
manufacturer’s documentation and user manuals (Siemens, 1997 & Siemens, 2004). 
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Table 4.1: Comparison of manufacturer specifications for vascular suite and E-
room 
Specifications Vascular Suite E-room 
Manufacturer Siemens Siemens 
Model Multistar 180° Multispace 
Swivel 
AXIOM Artis DMP 
Tube Megalix125/40/82CM-121W  
3 phase 
Megalix CAT/CAT Plus 
Maximum mA 320 mA small focus 
656 mA large focus 
320 mA for 1sec max 
Exposure: 640 mA at 125 kV 
Continuous operation: 1 000 mA at 
80 kV 
Maximum kV 125 kV 125 kV 
Detector type Image intensifier Amorphous silicon with CsI scintillator 
flat detector 
Installation date August 1997 March 2007 
DAP meter Diamentor dose-area product 
meter (PTW, Freiburg, 
Germany) fitted to the under 
couch tube assembly  
Dose measuring chamber for Card 
Collimator. Measuring chamber in 
primary collimator for measuring and 
display 
DAP meter unit display cGy.cm² µGy.m² 
Image intensifier 
formats/zoom options 
(Field diameters in cm) 
40, 28, 29. 14 48, 42,32,22 
mA=milli-Ampere, kV=kilo-Volt, CsI=Cesium Iodide, cGy.cm²=centi-Gray centimetres squared; µGy.m²=micro-Gray metres 
squared 
 
The BMI values were calculated from patients who were willing (Appendix G) and 
able to be weighed and measured during a six-month period (1 August 2008 to 31 
January 2009). A total of 136 useful BMI values was gathered over this period. 
These values were used to see how BMI relates to the radiation dose received. The 
correlation between BMI and dose received was grouped similar to that described in 
Chapter 3 (section 3.3), namely arterial outflow group, cerebral angiogram group and 
embolization group. 
 
4.3  DOSE CORRELATION RESULTS 
 
The results will be displayed in tables and graphs in the following sequence: 
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 Summary of statistics for all diagnostic and interventional procedures 
performed in the vascular suite and E-room (Table 4.2); 
 Comparison of mean DAP values of TFO procedure performed in the vascular 
suite and E-room (Table 4.3); 
 Mean DAP value distribution column for procedures in the vascular suite and E-
room (Figure 4.1); 
 Comparing dose values with BMI to dose values without BMI (Figure 4.2); 
 Dose received versus BMI values for the arterial outflow group (Figure 4.3); 
 Dose received versus BMI values for the cerebral angiogram group (Figure 
4.4); and 
 Dose received versus BMI values for the embolization group (Figure 4.5). 
 
In Table 4.2 the mean and median dose (mGy) and DAP (mGy.cm2) values are 
listed, as well as the maximum DAP values (mGy.cm²) for all diagnostic and 
interventional vascular procedures performed in the two rooms. This table does not 
give an indication of the spread of data (range), as the first and third quartile values 
were not calculated. 
 
Table 4.2: Dose and DAP value comparison of diagnostic and interventional 
fluoroscopic procedures performed in vascular suite and E-room (n=3073) 
Type of 
procedures 
Room n Mean DAP 
mGy.cm² 
Mean 
dose 
mGy 
Median 
DAP 
mGy.cm² 
Median 
Dose  
mGy 
Maximum DAP 
mGy.cm² 
Diagnostic Vascular 885 77 776 83 6 576 54 630 120 
 E-Room 247 86 424 68 4 071 27 3 415 200 
Interventional Vascular 1 874 33 815 51 764 13 741 020 
 E-Room 67 51 590 72 1 520 28 1 396 586 
n=number of procedures; DAP=dose area product; mGy.cm²=milli-Gray centimetres squared; mGy=milli-Gray 
 
More diagnostic and interventional vascular procedures were performed in the 
vascular suite (885+1874). Despite the smaller number of procedures performed in 
E-room, the mean DAP value was higher than in the vascular suite for both 
diagnostic and interventional procedures (86 424 and 51 590 mGy.cm² respectively). 
After performing a T-test for the mean DAP values in the vascular suite and E-room 
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it was seen that the higher mean DAP value for diagnostic procedures in E-room is 
not statistically significantly higher (p=0.2). The higher mean DAP value for 
interventional procedures in E-room also seems not to be statistically significant 
higher (p=0.6). The median DAP value was higher for the diagnostic procedures in 
the vascular suite, but for the interventional procedures this value was higher in E-
room. The maximum DAP value was higher in E-room than in the vascular suite for 
both diagnostic and interventional procedures. 
 
The skin dose for the above procedures was calculated taking the field area during 
the procedure into consideration. The first outlier of 3 415 200 mGy.cm2 was 
delivered during a TFO performed in E-room. A skin dose of 2 135 mGy was 
calculated for a field area of 40x40 cm. On closer inspection of the details of the 
outlier, it was seen that this procedure had been performed by a newly appointed 
registrar in E-room. This might be an explanation for the higher dose, as could be the 
fact that the procedure had been performed in the newly installed fluoroscopic room. 
The second outlier of 1 396 586 mGy.cm2 was during an EVAR performed in E-
room, with a calculated skin dose of 1 781 mGy for a field area of 28x28 cm. Upon 
perusal of the radiologist’s report, it was stated that the EVAR (interventional 
procedure) had been technically difficult as the patient weighed 158 kg. The height of 
the patient was not documented; thus, unfortunately, the BMI value could not be 
calculated.   
 
The mean dose (mGy) and the median dose (mGy) are higher for diagnostic 
procedures in the vascular suite. For interventional procedures the opposite is true, 
where both the mean and median dose (mGy) are higher in E-room. 
 
In Table 4.3 a comparison of mean DAP (mGy.cm²) values of the TFO procedures 
performed in vascular suite and E-room was made. 
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Table 4.3: Comparison of mean DAP (mGy.cm²) values of Trans-Femoral 
Outflow (TFO) procedures performed in Vascular Suite and E-room (n=530) 
Trans-femoral outflow Vascular Suite E-room 
Number of Procedures (n) 319 211 
Mean DAP (mGy.cm²) 63 850 85 427 
n=number of procedures; mGy.cm²=milli-Gray centimetres squared 
 
The small number of procedures performed in E-room makes the comparison of the 
mean DAP values (mGy.cm²) between rooms difficult. The number of other 
procedures performed in E-room was too small to allow for meaningful comparison. 
The only meaningful comparison to be drawn was between TFOs performed in both 
vascular suite (n=319) and E-room (n=211), as there was also a larger number of 
these examinations performed in E-room. The mean DAP is higher in E-room 
(85 427 mGy.cm2) than in vascular suite (63 850 mGy.cm2), however this does not 
seem to be statistically significant (p=0.2). E-room was installed during the study 
period (March 2007); thus, the fact that the room’s operation was not well-known at 
the time of the study could be a contributing factor. The protocol at the research site 
is that TFOs are performed in E-room by registrar radiologists. 
 
Figure 4.1 demonstrates the comparison of average DAP readings (mGy.cm2) 
received for diagnostic and interventional procedures performed in the two 
fluoroscopic rooms, namely the vascular suite and E-room. 
 
58 
 
mGy.cm²=milli-Gray centimetres squared; EVAR=Endoscopic vascular aneurysm repair; ERCP=Endoscopic retrograde 
cholangiopancreatography 
Figure 4.1: Mean DAP value distribution histogram for corresponding 
fluoroscopic procedures in the vascular suite and E-room 
 
When comparing the average DAP readings between the vascular suite and E-room, 
ERCP, EVAR, iliac stent, renal arteriogram and trans-femoral outflow had higher 
DAP values delivered in E-room than in the vascular suite. The procedures in the 
vascular suite which had higher doses were not significantly higher compared to the 
dose differences of procedures which were higher in E-room, with the exception of 
the renal stent, which had a mean DAP in E-room of 35 160 mGy.cm² and a mean 
DAP of 129 780 mGy.cm² in vascular. The same reason for the higher DAP values in 
E-room, as mentioned for Table 4.3, could apply regarding the newly installed 
fluoroscopic equipment. 
 
Figure 4.2 demonstrates a scaled graph which shows the dose values of patients 
with BMI values. A small number, when compared to the total amount, is comparable 
to dose values of patients without BMI values. 
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mGy=milli-Gray; BMI=body mass index 
Figure 4.2: Scaled frequencies comparing the trend of dose values with BMI 
and dose values with/without BMI  
 
The figure shows that the dose distributions for values with a known BMI and without 
BMI follow a comparable trend. A Mann-Whitney test was performed and only 136 of 
useful BMI values were obtained during the six-month period. This number is 
representative of the total of dose values after scaling. 
 
Figure 4.3 demonstrates the relationship between patient BMI and radiation dose 
received for procedures in the arterial outflow group. 
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mGy=milli-Gray vs=versus; BMI=body mass index 
Figure 4.3: Correlation of BMI value to the dose received for the arterial 
outflow group 
 
The trend line shows an increase in dose with increasing BMI (Figure 4.3), the R2 
value of 0.5299 indicates that dose and BMI might be slightly related, as R2 values 
between 0.5 and 0.9 are considered a strong correlation (Correlation Coefficient, 
2014). The correlation is affected by outliers, and removing the possible outlier 
(139 mGy, BMI 35) the R2 value changes to 0.4134, which indicates a moderate 
correlation. “The slope of a line can be defined as the ratio of the change in the y-
value over the change in the x-value (y-value, 2014).  
 
Figure 4.4 demonstrates the relationship between patient BMI and radiation dose 
received for procedures in the cerebral angiogram group. 
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mGy=milli-Gray vs=versus; BMI=body mass index 
Figure 4.4: Correlation of BMI value to the dose received for the cerebral 
angiogram group 
 
The BMI and dose do not appear to have a clear relationship for the cerebral 
angiogram group. The R2 value of 0.35 is indicative of a weak correlation; when the 
R2 value lies between 0.1 and 0.5 it is considered that dose and BMI are weakly 
related (Correlation Coefficient, 2014). If the outlier of 241 mGy and BMI value of 12 
is removed, the R2 value changes to 0.078, which demonstrates an even weaker 
correlation between dose and BMI for a cerebral angiogram  
 
Figure 4.5 demonstrates the relationship between patient BMI and radiation dose 
received for procedures in the embolization group. 
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mGy=milli-Gray vs=versus; BMI=body mass index 
Figure 4.5: Correlation of BMI value to the dose received for the embolization 
group 
 
It appears that BMI and dose are related for the embolization group; if the BMI 
increases, so does the dose received by the patient (Figure 4.5). From this graph, as 
well as the previous graphs, it is seen that all R2 values demonstrate a strong 
correlation when the R2 values lie between 0.5 and 0.9 (Correlation Coefficient, 
2014). When the isolated outlier with a dose value of 719 mGy and BMI value of 35 
is removed the correlation coefficient (R2) changes to 0.0573, which is considered a 
weak correlation. This demonstrates that a single case has a considerable effect on 
the fitted trend line. 
 
4.4  DISCUSSION 
 
The main findings are the data in Table 4.2, which show that E-room with the newer 
technology had higher mean and maximum DAP values for interventional and 
diagnostic procedures. These higher DAP values must be investigated, as it is 
expected that the newer technology will deliver lower doses. In a study of Seibert 
(2006) on a question as to how much better flat panel x-ray detectors (FDP) are in 
comparison to image intensifier digital systems, the answer was “significantly better”. 
This improvement in image quality of the FDP can be attributed to “the lack of 
geometric distortion, little or no veiling glare, a uniform response across the field of 
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view and improved ergonomics with better patient access” (Seibert, 2006, p. 173). A 
decrease in patient dose can be achieved by improved quantum efficiency. 
Compared to the vascular suite, only a small number of procedures was performed 
in E-room, and the values of these procedures were, in two cases, much higher than 
the hundreds performed in the other room. A single EVAR (interventional procedure) 
was performed in E-room during the study period. The high dose in this case can be 
attributed to the technical difficulty of the procedure due to the patient’s weight.  
 
In Table 4.3 the mean dose in E-room is also higher than in the vascular suite. The 
majority of procedures, both diagnostic and interventional, were performed in the 
vascular suite. E-room was also used for fluoroscopic procedures such as Ba-
swallows and Ba-enemas. These unexpected higher values in E-room might be 
attributed to the interventional and diagnostic procedure experience of the radiologist 
performing the procedure. Other specific patient problems, such as a grossly 
overweight patient, an extremely ill patient resulting in a complex case, or one with 
abnormal anatomy, could also contribute to higher DAP values. According to Miller, 
Kwon and Bonavia (2009) variation in radiation dose for individual cases can also be 
attributed to the level of practitioner training and experience which, will be discussed 
in Chapter 5. 
 
Grewal and McLean (2005) compared the dose of a Siemens Axiom ArtisdBC flat 
detector and a Toshiba conventional system. It was found that DAP meter readings 
for the units showed little difference, and no differences were seen for the two most 
commonly performed procedures. The Siemens Axiom Artis features the Combined 
Applications to Reduce Exposure (CARE) package. It may be that the operators had 
not been fully aware of all the dose reduction features available in E-room following 
installation, and thus this could also be a possible explanation for these higher 
values when compared to the older image intensifier system used in the vascular 
suite. Seibert (2006) describes this type of learning curve of adjustment as 
orientation, leaving room for improvement during the implementation of new 
technological advances.  
 
A study by Bor et al. (2005) showed that the use of smaller FOV options is more 
prevalent during interventional procedures, compared to diagnostic procedures. A 
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possible explanation for the higher mean and median dose (mGy) in the vascular 
suite for diagnostic procedures may be that smaller field areas were used during 
these procedures. “Differences in the irradiated field size may also cause the 
difference in radiation dose to patients” (Urairat et al., 2011, (http://www.biij.org). 
Dose is calculated by the following formula: DAP/area (cm2) (Bushberg et al., 2012, 
p. 306). Table 4.1 demonstrates the two rooms’ various zoom (field diameter) 
options. 
 
In Figure 4.1, ERCP, EVAR, iliac stent, renal arteriogram and trans-femoral outflow 
had higher average DAP readings in E-room than in the vascular suite. Although an 
increasing trend is seen for procedures in the arterial outflow group, the dose 
increase is relatively small for a large variation in BMI (Figure 4.2). From Figure 4.3 
dose and BMI seems to be related and it seems that BMI was a contributing factor in 
the dose the patient received. Additional contributing factors such as the experience 
of the radiologist, and technical factors such as field size and type of x-ray spectrum 
(altered by filtration and tube potential), scattered radiation may also be responsible 
(Faulkner et al., (nd)). Figure 4.4 shows no clear relationship between BMI and dose 
in the cerebral angiogram group. The researcher concludes that the lack of a clear 
relationship between BMI and dose in this group is due to the fact that patients’ head 
circumferences do not vary much between high or low BMI values; the thickness of 
the body part radiated stays more or less the same. However, it should be noted that 
although a correlation is noted, BMI is not the only contributing factor to the 
increased dose, as these embolization procedures tend to be long and complex 
(Figure 4.5) (Bor et al., 2005). “In medicine, comorbidity is the presence of one or 
more additional disorders (or diseases) co-occurring with a primary disease or 
disorder; or the effect of such additional disorders or diseases” (Comorbidity, 2014). 
One could also speculate that increased BMI tends to lead to comorbidity factors, 
such as cardiovascular disease, diabetes and hypertension that could influence the 
complexity of the procedure and in turn the dose. An increased BMI of a patient has 
the potential of increased dose due to difficulty in the technical aspects of the 
procedure, such as overlapping skinfolds that can make it difficult to perform the 
puncture in the femoral region. 
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The National Radiation Protection Board (NRPB, 1992) proposes the use of the UK 
national protocol to obtain a robust measure of the average-sized patient. It 
recommends choosing patients where the mean mass of the patients lies within 
±5 kg of 70 kg, and to exclude patients well outside the mass range of 70 kg ±10 kg. 
This method is applied when determining DRLs. This weight banding is to ensure 
that mean DAP values and related DRLs are representative of typical practice 
(NRPB, 1992). Another form of normalisation is using a normalisation factor derived 
from phantom measurements (Balter et al., 2011). The BMI values for patients in this 
study were not banded, as described. The BMI values for the measured patients 
represent the demographics of the research sample, as can be seen in Figure 4.2. 
 
Killewich et al. (2010) state that higher radiation doses are required to penetrate a 
thicker body mass in, for example, obese patients. For every 4.5 to 5 cm of depth the 
radiation is reduced by a factor of two. As the body part becomes thicker, 
fluoroscopy units will adjust the dose automatically in order to ensure a certain level 
of brightness. Obese patients can receive up to four to ten times more radiation than 
thinner patients. In a review article done by Koenig, Mettler and Wagner (2001), it is 
seen that skin injuries are generally associated with overweight or heavyset 
individuals. It can be explained, as low energy x-ray radiation is used during 
fluoroscopically guided interventional procedures. This radiation is quickly attenuated 
at the surface where entering the patient. The absorption is largest in the dermal and 
epidermal tissues. These attenuated x-rays have low penetrability and result in 
greater dose rates in large patients; during steep angulations of the x-ray tube, this 
can result in radiation injuries. 
 
4.5  CONCLUSION 
 
The results show that E-room’s mean DAP values were higher than in the vascular 
suite. This higher mean DAP value was only statistically significant for the 
interventional procedures. There were doses delivered in E-room which approached 
and exceeded the response threshold value for deterministic effects. This may not 
be significant considering the smaller number of procedures performed in E-room 
with marked outlier values. In cases where a procedure room, when compared to 
another procedure room, produces higher dose values, equipment should be 
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identified that requires investigation. Equipment repair, upgrade or replacement 
could be necessary if the dose reduction cannot be achieved without compromising 
image quality (Balter et al., 2011). Irrespective of using image intensifier systems or 
FDP systems, the operator always needs to be attentive of the equipment used and 
apply methods to reduce the radiation dose to our patients during the procedure 
(Seibert, 2006). 
 
Figures 4.3 and 4.5 show a strong relationship between BMI and fluoroscopic dose 
received during this study. Since the groups are so small, single cases have a large 
effect on the fitted trend line. If one compares the R2 value of the grouped 
procedures, there is a better correlation between BMI and dose during the arterial 
outflow and embolization group, when compared to the R2 value of the cerebral 
angiogram group. As is evident by the marked outlier (Table 4.2) during the EVAR 
procedure in E-room BMI – or, in this case, weight – can definitely be a major 
contributing factor. Normally one would expect a patient with a larger BMI to receive 
a higher dose as a result of higher tube output to penetrate thicker tissue which will 
result in more scatter.  The opposite can also be true where a normal size patient 
received a high dose resulting from longer fluoroscopy times and serial runs due to a 
complex procedure. One must not overlook the other factors influencing patient 
dose, such as the level of experience of the practitioner performing the procedure, 
angulations of the x-ray unit, distance and scatter. 
 
When performing an interventional procedure on an overweight patient, standard 
dose reduction protocols apply, but it is even more important to ensure that dose 
rates are kept as low as possible. This dose reduction can be achieved by assuring 
that the image intensifier is kept as close to the patient as possible, and the x-ray 
tube as far from the patient as possible. Such action can prevent skin injuries to the 
patient (Koenig et al., 2001).  
 
Increased exposure to patients during fluoroscopically guided diagnostic or 
interventional procedures can be facility-related or examiner-related. Facility-related 
factors can be improved by improving DSA equipment and putting protection 
systems in place. Examiner-related factors can be decreased by careful control of 
exposure parameters and the acquiring of procedural experience (Xu et al., 2011). In 
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the next chapter, another factor influencing the radiation dose, namely the 
relationship between the practitioner’s level of experience and patient dose, will be 
investigated. 
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CHAPTER 5  
INFLUENCE OF PRACTITIONERS’ LEVEL OF 
EXPERIENCE ON PATIENT DOSE  
 
5.1  INTRODUCTION 
 
In the preceding chapters, dose ranges were determined, high dose procedures 
identified, an evaluation was made of the relationship that a patients’ BMI has on 
dose, and older and newer technology were compared. In this chapter, and as part 
of a third objective of the study, additional factors, namely the technical knowledge 
and clinical experience of the practitioner performing the procedure that can also 
influence the dose, are presented. As previously discussed, interventional 
procedures are known to be of a complex nature, during which levels of radiation 
doses can reach and/or exceed threshold values for deterministic effects such as 
skin injuries. 
 
Various factors may influence the radiation dose delivered during such a procedure.  
According to the final report on Dose Optimisation in Fluoroscopically Guided 
Interventional Procedures (IAEA, 2010) the experience of interventionists is an 
important factor in dose management. From this report it has been shown that even 
under well-monitored and controlled training conditions, significantly larger doses 
have been delivered to the patients by interventionists who are less skilled than 
others. Bor et al. (2008) describe the practice where a senior radiologist normally 
supervises the training of registrar radiologists for both diagnostic and interventional 
procedures. Similar supervision is the current practice at the research site. The study 
of Bor et al. (2008) concluded that it will take some time for an inexperienced 
radiologist to perform complex interventions alone, but with increasing experience, 
this time usually reduces. In the process, the dose to the patient will reduce as the 
practitioner’s skills and knowledge increases. The validity of this conclusion will be 
tested for the research site in this chapter. 
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5.2  DEFINING CLASSES AND RELATIONSHIP TO DOSE 
 
To attain the objective, the methodology as described in Chapter 2 was followed. At 
the research site there was non-randomised allocation of patients to the doctors. The 
level of the practitioners’ experience was classified according to their qualifications 
and training as interventionist, consultant or registrar, as indicated on the data sheet.  
In Table 5.1 the classification according to the level of experience of the practitioner 
performing the procedures at the research site is described. The identity of the 
individual practitioner performing the procedure was also entered in the datasheet, 
as well as their class. If a consultant assisted a registrar, the procedure was 
allocated to the consultant and if an interventionist assisted a registrar or consultant, 
it was allocated to the interventionist. The radiation doses delivered by these three 
groups were evaluated and compared to similar procedures performed in both 
vascular suite and E-room. 
 
Table 5.1: Classification of practitioners performing procedures at the 
research site 
Class group Description of Experience 
Registrar A junior doctor undergoing specialty training in the field of radiology 
on a recognised Radiology Training Scheme (Trainee radiologist, 
2014).  
 
Consultant A qualified radiologist subspecialising and receiving specialised 
training in interventional radiology (Consultant radiologist, 2014). 
Interventionist A specialist radiologist in interventional radiology, who uses image 
guidance methods to gain access to vessels and organs and use the 
least invasive treatments, which previously would require surgery 
(Interventional Radiology, 2014). 
 
The same grouping of procedures was used as in Chapters 3 and 4. The arterial 
outflow group and cerebral angiogram group were used for comparison. These two 
groups involved registrar radiologists (n=24), consultants (n=2) and interventionists 
(n=2) at the research site, and were compared for each of the classes of 
practitioners (Table 5.1). The mean dose delivered by each class group was 
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compared for both the arterial outflow and cerebral angiogram group. The mean 
dose for each group of doctors was calculated from the DAP and entry portal size of 
field (field area in cm²) used for these procedures. Dose was calculated as DAP/field 
area (Bushberg et al., 2012, p. 306). The dose distribution for each of the class 
groups for the arterial outflow and cerebral angiogram group was also compared. 
The embolization group was not included in this comparison, as only interventionists 
and some consultants performed these procedures. 
 
5.3  RESULTS 
 
The results are displayed in tables and graphs in the following sequence: 
 The mean doses for the arterial outflow group performed by the three classes 
of radiologists (Figure 5.1); 
 Dose distribution for practitioners as box plots for the arterial outflow group 
(Figure 5.2); 
 The mean doses for the cerebral angiogram group performed by all three 
classes of radiologists (Figure 5.3); 
 Dose distribution for practitioners as box plots for the cerebral angiogram group 
(Figure 5.4); 
 Relationship of DAP and registrar A’s experience over time for the arterial 
outflow group (Figure 5.5); and 
 Relationship of DAP and registrar B’s experience over time for the arterial 
outflow group (Figure 5.6). 
 
Figure 5.1 demonstrates the mean dose delivered during the arterial outflow group 
by the three classes of practitioners.  
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mGy=milli-Gray; n=number  
Figure 5.1: Mean dose bar graph with 25th and 75th percentile error bars for 
arterial outflow group performed by consultants, registrars and 
interventionists 
 
At the research site, registrar radiologists receive training on diagnostic vascular 
procedures such as trans-femoral/trans-brachial outflows and aorta-grams which 
compose the arterial outflow group. The registrars performed most of these 
procedures (n=422) followed the interventionists (n=133) and the consultants 
(n=108).  From Figure 5.1 it is seen that the procedures that the registrars performed 
had the highest mean dose (43 mGy) followed by the interventionists (41 mGy) and 
the consultants (39 mGy). The ranges for the first and third quartile values 
correspond fairly well, indicating that there is little variation in the dose distribution of 
the various doctor classes. The negative error bars were calculated using the 25th 
percentile and the positive error bar was calculated using the 75th percentile. The 
overlapping error bars indicate no significant variation amongst the three classes.   
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Figure 5.2 demonstrates the dose distributions for the three classes of practitioners 
in the arterial outflow group as box-and-whisker plots. 
 
 
mGy=milli-Gray 
Figure 5.2: Box-and-whisker plots of dose distributions for registrars, 
consultants and interventionists for the arterial outflow group 
 
The horizontal line within the box indicates the median; boundaries of the box 
indicate the 25th and 75th percentile; and the whiskers indicate the highest and lowest 
values of the results. As can be seen from Figure 5.2, this is not a normal 
distribution. The distribution from the first to the third quartile dose values for all three 
classes of practitioners are more or less the same. The third quartile values to 
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maximum values of the registrars’ and interventionists’ distribution vary more, 
compared to that of the consultants. This is indicative of a positively skewed 
distribution, which can be expected as the procedures performed by the registrars 
had a slightly higher mean dose than the interventionists, which in turn had a higher 
mean dose than the consultants (Figure 5.1). A single outlier of 2 135 mGy in the 
registrars’ data set was not included in the plot, as this was an isolated occurrence 
that deviated significantly from the rest of the data set. 
 
Figure 5.3 demonstrates the mean dose delivered during the cerebral angiogram 
group by the three classes of practitioners. 
 
 
mGy=milli-Gray; n=number 
Figure 5.3: Mean dose bar graph with 25th and 75th percentile error bars for 
cerebral angiogram group performed by consultants, registrars and 
interventionists 
 
Registrar radiologists also receive training for cerebral angiograms, which is a 
diagnostic vascular procedure that includes four- and six-vessel angiograms. From 
Fig 5.3 it can be seen that the registrars delivered a higher mean dose (159 mGy) to 
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patients than the consultants (141 mGy) and interventionists (141 mGy), who 
achieved the same mean dose. The registrars performed the smallest number 
(n=63) followed by the consultants (n=96), while the registrars performed the most 
cerebral angiograms (n=128). The ranges for the first to third quartile correspond, 
indicating that there is little variation in the distribution of the various classes’ doses. 
 
Figure 5.4 demonstrates the dose distribution for the three classes of practitioners in 
the cerebral angiogram group as box-and-whisker plots. 
 
 
mGy=milli-Gray 
Figure 5.4: Box-and-whisker plots of dose distributions for registrars, 
consultants and interventionists for the cerebral angiogram group 
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The horizontal line within the box indicates the median; boundaries of the box 
indicate the 25th and 75th percentile; and the whiskers indicate the highest and lowest 
values of the results. As can be seen from Figure 5.4, this is not a normal 
distribution. The distribution from the first to the third quartile values for all three 
classes of practitioners is more or less the same. The third quartile values to 
maximum values of the consultants’ distribution vary more. The boxes for all three 
classes of practitioner are shifted towards the lower dose values, thus it is positively 
skewed. 
 
Figure 5.5 demonstrates registrar A’s DAP values for consecutive patients in the 
arterial outflow group over a time period. 
 
 
mGy.cm
2
=milli-Gray centimetres squared 
Figure 5.5: Relationship of DAP and registrar A’s level of experience over time 
for the arterial outflow group. 
 
Registrar A performed n=44 procedures during the three-year period of the study. 
There is not a large change in DAP values over the time period. As seen in Figure 
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Figure 5.6 demonstrates registrar B’s DAP values for consecutive patients in the 
arterial outflow group over a time period. 
 
 
mGy.cm
2
=milli-Gray centimetres squared 
Figure 5.6: Relationship of DAP and registrar B’s level of experience over time 
for the arterial outflow group. 
 
In Figure 5.6 there is a slight decrease in DAP values over the given time period. 
This registrar performed n=57 procedures during the time of the study. It is 
interesting to note that despite the two outliers, the DAP values seems to have 
slightly decreased over the time period. 
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(43 mGy) followed by the interventionists (41 mGy) and then the consultants 
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possible explanation for this may be the fact that at the research site it is an 
unwritten rule that consultants and especially interventionists will perform the more 
complex cases, such as critically ill patients and patients with a high BMI value. 
These more complex cases usually take longer, which will contribute to the radiation 
dose the patient receives. 
 
The skewed distribution in Figure 5.2 can be attributed to the level of experience of 
the practitioner. The higher maximum value of the interventionists can be due to the 
fact that they perform the more complex arterial outflow cases, which include the 
patients with a higher BMI value, which also has the effect of increasing the dose. 
Chapter 4 (Figure 4.3) demonstrates that there is a strong correlation between BMI 
and dose received in the arterial outflow group. The outlier with a value of 
2 135 mGy mentioned previously exceeds the possible – maybe generally accepted 
– level that could be considered a threshold value for deterministic effects (ICRP, 
2000). This was an isolated occurrence. 
 
From Figure 5.3 the mean dose delivered during the cerebral angiograms performed 
by the registrars is significantly higher (159 mGy) than those of the consultants and 
interventionists (141 mGy). During the study period, the interventionists performed 
the majority of procedures in the cerebral angiogram group (n=128), followed by the 
consultants (n=96) and the registrars (n=63). The larger number of procedures 
performed by interventionists with a lower mean dose can possibly be attributed to 
their skill and experience. The selection of the carotid and vertebral arteries for 
imaging can be difficult if a patient has tortuous vessels and abnormal anatomy. In 
such cases, the skill of the practitioner performing the procedure plays a vital role in 
patient doses (Bor et al., 2008). Xu et al. (2011) suggests that registrars reduce 
radiation exposure during cerebral angiography by acquainting themselves with 
cerebral artery anatomy and training with catheter-wire manoeuvres. 
 
The skewed distribution in Figure 5.4 can be due to the fact that consultants and 
interventionists perform more complex cerebral angiogram cases, compared to 
registrars. 
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In a study conducted by Xu et al. (2011), a comparison was made between the first 
40 consecutive cerebral DSA procedures performed by 13 trainees on an Axiom 
Artis system (Siemens, Germany). These procedures were grouped as the first 20 
and the second 20 procedures. According to Xu et al. (2011), a learning effect is 
present which is mostly seen for the first 20 procedures. This effect may be seen as 
shorter exposure time and lower radiation exposure with the gaining of performing 
experience by the trainee. The DAP, fluoroscopy time, number of cine frames, and 
procedure time were recorded. It was found that there was a marked decrease in 
DAP and fluoroscopy times as the trainees gained procedure experience. Procedure 
time and number of cine frames did not have a marked change. The higher radiation 
exposure during the procedure performed by a trainee is due to longer fluoroscopy 
times, searching for arteries, and manipulation of catheters and guide wires. 
 
The results of this study motivated the decision to compare the two registrars who 
performed the most patients in the arterial outflow group over a period of time. This 
was done to evaluate if there was a noticeable learning effect present, as DAP 
values from registrars had the most room for improvement (reduction). However, 
there was no clear decrease in DAP (Figure 5.5) as is expected as a practitioners’ 
level of experience and technical knowledge increased: the learning effect. This 
specific registrar was in the beginning of their training, as indicated by the 
commencement date of registrar training (November 2006) on employment records. 
A possible explanation can be that the registrar performed more complex cases 
during the last period of training and a further reduction in DAP values was not 
possible. This can be due to the turning point discussed by Xu et al. (2011) where 
the learning effect becomes insignificant.  
 
When evaluating registrar B’s performance (Figure 5.6) there is a slight decrease in 
DAP values over the time period. From employment records this registrar started 
training in September 2006, two months prior to registrar A. It must be stressed that 
there was non-randomised patient allocation to the doctors performing these 
procedures. Registrar B performed 13 more arterial outflow procedures for the 
duration of the study than registrar A. When comparing these two figures it is seen 
that registrar A did not perform these procedures as continuously as registrar B, who 
performed procedures in the arterial outflow group ongoing for the duration of the 
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study. This could be a possible explanation for registrar A’s DAP values not 
decreasing over time: that they did not perform these procedures continuously due to 
roster allocations. However the change in DAP values for registrar B is almost 
negligible and no apparent conclusion can be made in this regard. 
 
In order to evaluate the DAP values of the different classes of practitioner for both 
the arterial outflow group and the cerebral angiogram group at the research site, a 
comparison was made with a similar study conducted by Bor et al. (2008). During 
this study, a comparison was made between the DAP values delivered during 
cerebral and lower limb examinations performed by junior radiologists (n=7) and a 
senior radiologist. It was conducted at a single radiology department of a university 
hospital where junior radiologists are trained. A Siemens Multistar Plus TOP 
(Siemens, Erlagen), with 40, 28, 20 and 14 cm input field diameters was used for all 
the procedures – the same as one of the x-ray machines for the research site of this 
study. During the study at the research site values for both vascular suite (Siemens 
Multistar) and E-room (Siemens Axiom Artis) were pooled; however, most of the 
procedures were performed in the vascular suite. During the study of Bor et al. 
(2008), detailed documentation of FOV used, number of frames, fluoroscopy time, 
DAP for fluoroscopy and DAP for radiography (exposure) was done. For comparison 
purposes it will be assumed that a junior radiologist during his study is comparable to 
a registrar radiologist in this study, and a senior radiologist to an interventionist. 
Lower limb examinations are comparable to the arterial outflow group and cerebral 
examinations to the cerebral angiogram group. 
 
In Table 5.2 a comparison is made between mean DAP received during lower limb 
and cerebral examinations at the research site and a study conducted by Bor et al. 
(2008). 
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Table 5.2: Comparison of mean DAP values of lower limb and cerebral 
examinations of the research site and study of Bor et al. (2008) 
Average Values Junior/Registrar 
Radiologists 
Senior Radiologist/ 
Interventionists 
Junior to Senior  
Ratio 
Lower limb examinations: 
DAP (mGy.cm
2
) - Bor et al. 140 (n=30) 240 (n=30) 0.58 
DAP(mGy,cm
2
) - Research site 680 (n=421) 660 (n=133) 1.03 
Cerebral examinations: 
DAP (mGy.cm
2
) - Bor et al. 890 (n=30) 840 (n=30) 1.06 
DAP(mGy.cm
2
) - Research site 1 270 (n=63) 1 100 (n=128) 1.15 
DAP=Dose Area Product; mGy.cm
2
=milli-Gray centimetres squared; n=number 
 
The mean DAP values for the research site for both the lower limb and cerebral 
examinations for both the groups of doctors are higher than for the study conducted 
by Bor et al. (2008). At the research site the number of procedures (n) performed 
was more than that of the Bor et al. (2008) study, as they compared only 30 patients 
performed by each group of doctors in the lower limb and cerebral categories. The 
junior to senior ratios of the research site shows that registrar radiologists delivered a 
slightly higher mean DAP to their patients than the interventionists. They explained 
that the reason for the similar dose values for junior and senior radiologists during 
cerebral examinations was the use of standard acquisition protocols.  
 
Standard acquisition protocols for both lower limb and cerebral examinations also 
exist at the research site. Bor et al. (2008) attribute the higher DAP values of junior 
radiologists to the frequent use of smaller FOVs (field diameter), which they use 
during placement or manoeuvring of the catheter and/or guide wire. 
 
5.5  CONCLUSION 
 
The objective of this chapter was to determine what effect the level of the 
practitioners’ experience had on patient dose. The results indicate that the mean 
doses (mGy) delivered by registrar radiologists are slightly higher than that of the 
consultant and interventionists for both the arterial outflow and cerebral angiogram 
groups. As stated, normal practice at the research site would be that consultants and 
especially interventionists perform more complex cases and these are normally more 
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difficult, longer cases that will contribute to a higher radiation dose the patient 
receive (Faulkner et al., (nd)). In Figure 5.3 it is seen that although the number of 
procedures performed by interventionists is more, patients received a lower mean 
dose (mGy), this lower dose can possibly be attributed to their level of experience. 
 
Xu et al. (2011) describes a learning effect that exits in the early stage of training, 
where a significant decrease in fluoroscopic time and radiation exposure is seen as 
the practitioner accumulates experience. There is a turning point, however, where 
this effect becomes less significant, normally after the first 20-30 procedures. This 
point is very important when improving the training programme for DSA procedures 
(Xu et al., 2011). In Figure 5.5 and 5.6, no clear decrease in DAP values is seen 
after 20-30 procedures that would have been indicative of the turning point as 
discussed by Xu et al. (2011). As this turning point was not clearly demonstrated, we 
argue that this could be indicative to the varied patient composition and complexity of 
cases at the research site. There was non-randomised patient allocation to the 
practitioners performing these procedures. Only the extremely complex cases would 
have been performed or assisted by either the consultant or the interventionist. This 
would possibly be the case only when the registrar could not perform the procedure 
alone. 
 
During a comparison of DAP values between a study completed by Bor et al. (2008) 
and DAP values of the research site, it showed that these values are comparable. 
The mean DAP values at the research site were higher for both the registrars and 
interventionists for cerebral and lower limb procedures. The data from the research 
site that were compared with the data during Bor et al.’s study (2008) were more 
extensive, because more procedures were performed.  
 
The fluoroscopic equipment used in the study conducted by Bor et al. was similar to 
the Siemens Multistar (vascular suite) at the research site. It must be noted that 
when compared, the Siemens Axiom Artis (E-room) delivered higher dose values 
than the Siemens Multistar, as discussed in Chapter 4 (Table 4.2). The higher DAP 
values at the research site can be attributed to this increase. It is important that 
during the junior radiologist training programme they learn the technical aspects of 
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the operating system and the relationship between equipment factors and patient 
doses (Bor et al., 2008). 
In the next chapter, all the results obtained during this study will be critically 
evaluated. Discussion of the comparison done with studies published in the literature 
will be presented. Limitations experienced in this study will also be discussed and 
recommendations arising from this study will be made. 
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CHAPTER 6 
CONCLUSIONS AND RECOMMENDATIONS 
 
6.1  INTRODUCTION 
 
Interventional radiology is a fast developing field, playing an essential role in 
diagnosing and especially in treating patients with pathologies in nearly every organ 
system. Because interventional procedures use radiation as an imaging tool, this 
imaging modality needs to carry the responsibility for limitation, justification and 
optimisation. All role-players should try to optimise the dose to their patients and, in 
doing so, will in turn decrease the dose to personnel (Stecker et al., 2009). After a 
critical evaluation to all the information available in the literature, it was concluded 
that radiation workers at the research site were knowledgeable about radiation 
during fluoroscopically guided interventional procedures and documented the dose 
to the patient rigorously. But the critical evaluation of the dose, routine follow-up and 
optimizing of dose were lacking. This identified gap led to the setting of research 
objectives. 
 
The objectives of the study were threefold. The primary objective of the study was to 
determine the doses and dose ranges to patients. A secondary objective was to 
identify specific high dose procedures to individual patients and the population; by 
using the results obtained, an awareness of dose levels and their relationship to 
radiation effects (injuries) will be created at the research site. A third objective was to 
investigate the factors influencing these doses.  
 
6.2  ATTAINING THE RESEARCH OBJECTIVES 
 
As stated, one objective of this study was to determine the dose distribution for 
specific diagnostic and interventional procedure types. Dose ranges for diagnostic 
and interventional procedures at the research site were not available.  
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6.2.1  Dose ranges for diagnostic and interventional procedures (2.4.1) 
 
Similar diagnostic and interventional procedures were grouped to increase the 
number of patients in each group and thus facilitate a statistically significant 
comparison. In keeping with the objective, the dose distributions of these procedures 
were evaluated. The arterial outflow group was performed most often, followed by 
the cerebral angiogram group and the embolization group. The arterial outflow group 
and embolization group did not have a symmetrical distribution, while the cerebral 
angiogram group had a normal or bell-shaped distribution. DAP values were used as 
a dose measure (See Chapter 1, section 1.3). The DAP values of these mentioned 
procedures were used to calculate DRL values to compare with published values. 
The research site values for the three grouped procedures exceeded published 
values, as seen in Table 3.4. It must be noted that the grouped procedures at the 
research site were compared to procedures that were the most similar to those in the 
literature (Aroua et al., 2004). 
 
6.2.2  Identifying specific high dose procedures which may require patient 
follow-up to individual patients and the population (2.4.2) 
 
Procedures were ranked according to doses delivered (Table 3.2 and 3.3). Renal 
arteriogram, TFO, EVAR, four-vessel angiogram, ERCP and TBO were seen to be 
the procedures that delivered high doses to individual patients and to the population. 
The renal arteriogram (4 165 mGy) and TFO (2 135 mGy) had isolated occurrences 
where the suggested maximum level at which deterministic effects could be 
expected was exceeded, and thus radiation injury could realistically be expected to 
be caused to the patients. Upon closer inspection, the upper quartile values (75th 
percentile) were significantly lower at 262 mGy and 53 mGy respectively. 
Reassuringly, none of the 75th percentile values of any of these identified procedures 
were near to or approaching the response threshold value for deterministic effects. 
The generally used meaningful dose range lies between the 25 th and 75th percentile 
values, which give an indication as to where the central 50% of dose values will be. 
Thus, this range encompasses the doses that could realistically be achieved without 
changing any of the equipment or the outcomes of the procedures being performed. 
The upper quartile value is important when obtaining informed consent from a 
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patient, as only 25% of all patients received doses higher than this value during the 
study period. The upper quartile value is often used in the literature as the DRL for 
that specific procedure. Nonetheless, optimisation of these procedures’ doses will 
have to take place and the greatest effect will be seen to the population dose, as 
these procedures are performed more often. 
 
In order to compare the research site’s DAP values, some values were compared to 
documented values in the United Kingdom, Germany and Switzerland (only femoral 
angiography values for these countries were available) (Hart, Hillier & Wall, 2009) in 
Table 3.5. Biliary drainage, oesophageal dilatation and stent of the locally performed 
procedures delivered lower or on par radiation doses to that in the literature. 
 
6.2.3  Comparison of doses for similar procedures performed in the two 
different venues, namely the vascular suite and E-room (newer 
technology) (2.4.3) 
 
A further breakdown in evaluating the research site’s overall dosimetric performance 
during diagnostic and interventional vascular procedures is a comparison of doses in 
the two different venues. 
 
DAP values of similar procedures performed on older and newer technology were 
compared at the research site. The Siemens Axiom Artis in E-room was installed 10 
years after the Siemens Multistar in the vascular suite. The newer technology had a 
flat panel detector, which was expected to deliver lower patient doses. This was not 
the case, and although a smaller number of procedures was performed in the room 
equipped with the new technology (E-room), the patient doses in this room were 
higher. At the research site, registrars would normally perform most of the diagnostic 
cases in E-room, namely the trans-femoral outflows and cerebral angiograms, as 
part of their training. As mentioned in Chapter 5, the level of experience can be 
linked to the dose a patient will receive. However, the interventional procedures 
performed by interventionists and consultants in E-room also had higher DAP and 
dose values compared to the procedures performed in the vascular suite (old 
technology). As stated, one of the explanations for the higher dose in E-room could 
be due to the fact that the operation of the room was not yet well known at the time 
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of the study. The operators might not have been knowledgeable about all the 
available dose reduction features of the fluoroscopic equipment. 
 
6.2.4  Correlation of the BMI value of the patient relates to the dose received 
(2.4.4) 
 
Various factors can play a role in the dose a patient will receive, including the body 
habitus of the patient. A third objective of the study was to demonstrate the 
correlation between the body mass index (BMI) value of the patient and how this 
value relates to the dose received. Weighing and measuring patients were not part of 
the departmental procedure at the research site at the time of the study. This 
practice was only done during the six-month period of the prospective part of the 
study. For the retrospective part of the study, no patient stratification according to 
BMI was made. This means that the retrospective data represent the present patient 
population of the research site (Kloeckner et al., 2012). The small number of useful 
BMI values that was obtained during the six-month period was representative of the 
total number of the dose values without BMI. The BMIs and dose during the arterial 
outflow (Figure 4.3) and embolization group (Figure 4.5) evaluation tended to 
indicate a strong relationship, but weakly related during the cerebral angiogram 
group (Figure 4.4). As discussed, BMI alone cannot be a measure of expected dose. 
The patient’s thickness (area irradiated) plays a major role in beam attenuation and 
dose received. 
 
6.2.5  The relationship of the practitioner’s level of experience on skin dose 
(2.4.5) 
 
Another factor that was evaluated was the effect that the skill of the practitioner 
performing the procedure had on the radiation dose received during procedures. The 
research design of this study was quantitative with a retrospective and partly 
prospective part (Chapter 2, section 2.5). There was no randomising in the 
retrospective part of the study and for the prospective part it was not known to the 
practitioners that the dose values of patients that they were performing procedures 
on would be analysed. As described by Kloeckner et al. (2012), this method of data 
collection represents the daily clinical routine and avoids bias, which is 
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advantageous. A true way to compare the impact of the practitioner’s skill on dose is 
to make use of a prospective randomised trial with graded complexity, which would 
have ethical dilemmas (Kloeckner et al., 2012). 
 
When comparing the mean doses delivered by the three classes of practitioner for 
the arterial outflow (Figure 5.1) and cerebral angiogram group (Figure 5.3), the 
registrars delivered higher mean doses to the patients than the consultants and 
interventionists. The distribution of these doses was skewed to the higher dose 
values (Figure 5.2 and 5.4). Training of registrars must include dose optimisation 
techniques and not only procedure protocol. 
 
6.3  LIMITATIONS OF THE STUDY 
 
6.3.1  Retrospective design 
 
The retrospective design of a part of this study can be seen as a limitation. This part 
represents realistic values, as operators and physicians were not aware that they 
were being monitored. In a similar study by Pitton et al. (2012) this type of design 
avoids bias from any study and, conversely, if personnel are aware of dose 
monitoring, study-recorded DAP values can be too low. 
 
6.3.2  Methodological errors 
 
Although all reasonable measures were implemented to ensure the accuracy of the 
data captured, the following are limitations: 
 
 The researcher was not employed full-time at the vascular suites during the 
research period and thus was not available to oversee the accuracy and 
classification of data entries during each diagnostic/interventional procedure. 
This was critical during the six-month period when weight and height were to be 
documented. As a result, only a small number of patients was weighed and 
measured. 
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 Power failures due to load shedding and power outages influenced the data, as 
the DAP meter resets to zero in case of a power failure; thus, the previous 
readings for that specific procedure were lost. The number of missing DAP 
meter readings due to these events were reflected in the total number of 
incomplete records (n=230) and, as a result, all these entries had to be 
excluded from the study.   
 Systematic errors were kept as low as possible as a standard departmental 
procedure for documenting procedure type, and the patient detail used 
comprised patient information, procedure, doctor performing the procedure, 
DAP value and screening time. 
 
6.3.3  Small number of procedures  
 
Although a large number of procedures was performed over the three-year period, 
some were performed less often. During statistical analysis, it was found that the 
number (n) of some of the 76 types of procedures was too small to be statistically 
significant. There is a level of uncertainty whether the procedures had been correctly 
classified before the data were documented. This smaller number of procedures led 
to the grouping of similar procedure types. In the study of Pitton et al. (2012, p. 1492) 
it is stated that “the comparison of our DAPs to those in reports from the literature is 
challenging because of the differing grouping of interventions, which has the 
potential to completely alter the values.” 
 
The research site is a training hospital. It was found that there were some 
practitioners, especially the registrars, who performed only a small number of 
procedures during the three-year period. This made the evaluation of how a 
practitioner’s level of experience influenced the dose that the patient would receive 
difficult. The number of dose values with known BMI values, although comparable to 
the rest of the data, is small. This makes the correlation between BMI and dose 
difficult.   
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6.4  RECOMMENDATIONS ARISING FROM THE STUDY 
 
As evident from the data, patients receiving procedures such as renal arteriogram, 
TFO, EVAR, four-vessel angiogram, ERCP and TBO may be at risk of receiving high 
radiation doses. 
 
6.4.1  Obtaining consent for identified high dose procedures 
 
A patient must give consent to diagnostic and interventional procedures. But patients 
undergoing any of these aforementioned procedures must be specifically informed of 
possible radiation effects when obtaining consent the patient without causing 
unnecessary radiation phobia. 
 
6.4.2 Radiation dose documentation for identified high dose procedures 
 
Evaluate the radiation doses of all patients that had undergone any of these 
procedures immediately after the procedure. There is a function on most modern 
fluoroscopic equipment today which indicates where the patient’s dose lies in relation 
to the response threshold for deterministic effects (2 Gy/2 000 mGy). At the research 
site, E-room had the dose indicator (if the weight and height of the patient has been 
entered), while the vascular suite (older technology) did not have such a function. If 
the fluoroscopic equipment is not equipped with such a function, this evaluation can 
be made by calculating the dose the patient received for the specific procedure. This 
calculation must be made from the DAP value/area (Chapter 2, section 2.10).  
 
6.4.3  Follow-up for breeching of response thresholds 
 
The result must be checked against the suggested maximum level for deterministic 
effects, namely how close to 2 000 mGy the patient dose was. If the response 
threshold value for radiation injuries had been exceeded or approached, the patient 
would require follow-up. The patient, radiologist and referring clinician should be 
notified of this dose and possible skin injuries that might occur. Previous fluoroscopy 
procedures must also be taken into account to determine the cumulative dose. At 
most interventional suites, patient dose reports are not automatically archived or 
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analysed (Vañó et al., 2013). Currently at the research site, patient dose values are 
recorded in a procedure book and entered manually onto the Picture Archiving and 
Communicating System (PACS). 
 
6.4.4  Procedure allocation 
 
The practice at the research site that senior practitioners perform more complex 
cases should be reiterated. Supervision by consultants and interventionists of 
registrars’ procedures must be reinforced. They also need to step in or take over if a 
registrar is struggling with the technical execution of the procedure. These 
recommendations and the subsequent dose optimisation programme will ensure that 
doses to patients are reduced and are kept as low as possible.   
 
6.4.5  Further research 
 
As is evident by the results of this study, radiation doses to patients receiving 
interventional procedures can be high and subsequent radiation injuries can be a 
reality in complex procedures. Following the implementation of the proposed dose 
optimisation programme, further research needs to be conducted. The efficacy of the 
dose optimisation programme to reduce dose should be evaluated. A focused 
evaluation of dose optimisation of the identified high dose procedures to the 
individual patient and the public is required. Patient and staff doses are closely 
related and, in addition to patient doses, staff doses during interventional procedures 
can be investigated. 
 
6.5  PROPOSED DOSE OPTIMISATION PROCEDURE PROTOCOL FOR THE 
RESEARCH SITE 
 
From the above information it is necessary to compile a procedure with which 
radiation dose to the patient can be monitored and, where applicable, reduced. The 
data from this study will be used to initiate a dose optimisation programme. As stated 
in Chapter 1 (section 1.2.10-1.2.14) the SIR has released “Guidelines for Patient 
Radiation Dose Management” (Stecker et al., 2009), to be used for radiation dose 
management linked with interventional radiological procedures. The suggested 
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structure of these guidelines was used in the proposed dose optimisation 
programme for the research site. This dose optimisation programme will be 
recommended to the head of the radiology department. Departmental protocols for 
the research site will be revised as follows: 
 
6.5.1  Pre-procedural planning protocol 
 
Individual training: Radiographers and other personnel working in the interventional 
radiology suite will receive initial training in patient radiation management. Annual 
refresher training will take place in radiation management on the department’s 
policies and government regulations. Both actions will be the responsibility of the 
radiation control officer in conjunction with the medical physicist of the radiology 
department.   
 
Informed consent: Patients and, in the case of a minor, the parents or legal guardian 
will be informed by the radiographer of possible radiation risks before the procedure 
is performed. Specific high dose procedures have been identified (see Chapter 3, 
Table 3.2 and 3.3). The radiologist performing the procedure will question the patient 
regarding previous radiation exposure. This information will be brought to the 
attention of the radiologist and taken into account during the planning process of the 
new procedure. 
 
Procedure planning: All relevant pre-procedure imaging available on the PACS at the 
research site must be reviewed, and not merely reports. These images may help in 
reducing procedure time, in reducing fluoroscopy time and the amount of 
fluoroscopic images needed, and in lowering the overall complication rates of the 
specific procedure. Non-invasive cross-sectional imaging modalities (magnetic 
resonance (MR) imaging and ultra-sonography etc.) must be used as part of the 
planning process with regard to access routes and device choices as proposed by 
Stecker et al. (2009). 
 
Patient’s BMI: Weigh, measure and document all able patients’ weight and height. 
These values must be entered in E-room. This will result in the generation of an 
automatic dose indicator at the end of the procedure. This will be an easy measure 
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to see where a patient’s dose lies in relation to 2 Gy (response threshold). This will 
also be used in the new vascular suite, as one needs to give an indication of a 
patient’s weight (for example, <70 kg or >90 kg) which will be used for automated 
dose calculation. 
 
6.5.2  Intra-procedural management protocol 
 
Procedural radiation monitoring: The radiographer will monitor the dose during the 
procedure, using the table as in Chapter 1 (section 1.2.12, Table 1.1) as reference. 
 
The doctor performing the procedure will take into consideration the radiation dose 
that the patient has already received, as well as the dose needed to complete the 
procedure. Bi-plane units’ doses will be evaluated individually if the fields do not 
overlap, but will be added if they do. 
 
Dose minimisation protocol for implementation at the research site: Radiographers 
and radiologists will receive extensive training, conducted by the radiation control 
officer and medical physicist, in the implementation of the dose minimisation 
protocol. This protocol will contain the following major points:  
 Use the lowest pulse rate fluoroscopy mode where possible; 
 Limit the fluoroscopy time; 
 Limit the number of DSA frames and runs to the minimum; 
 “Frame grab” where possible the fluoroscopy images and store fluoroscopic 
scenes (films) for documentation; 
 Collimate to area of interest using virtual collimation; 
 Elevate the table and keep the image detector as close to patient as possible 
and the x-ray tube as far as possible from the patient’s skin; 
 Limit the use of magnification; and 
 C-arm angles should be varied during the procedure without interfering with the 
conduct of the clinical procedure. 
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6.5.3  Post-procedural care protocol 
 
Dose documentation: The radiographer will record all patient and procedure data 
correctly. The radiographer and radiologist performing the procedure must evaluate 
and analyse patients’ DAP values immediately after completion of the procedure for 
all procedures that involve fluoroscopy, but specifically for the identified high dose 
procedures. They will then determine if the patient will require follow-up by 
comparing the patient’s dose to the table from the SIR guidelines (Chapter 1, section 
1.2.11, Table 1.1). The radiographer will inform the radiologist when suggested 
maximum levels have been exceeded: if the patient’s peak skin dose has reached 
2 000 mGy, kerma-air-product has exceeded 500 Gy.cm², or the fluoroscopy time 
has exceeded 60 minutes. If there was any uncertainty of the dose the patient has 
received, a medical physicist would help evaluate the dosimetric aspects of that 
procedure. The radiologist will then schedule a follow-up with the patient’s referring 
clinician. 
 
Patient follow-up: All patients who received dose values that reached suggested 
maximum levels for deterministic effects need to be followed up. Follow-up is 
recommended even if the dose values were lower, but the same anatomical site has 
recently received radiation. Such a patient, who has received a noteworthy amount 
of radiation, will be given clear instructions for self-examination of the irradiated area. 
As part of the post procedural care protocol proposed for the research site, a patient 
who has received a substantial amount of radiation as indicated by the SIR 
guidelines during either a diagnostic or interventional procedure will be given 
instructions about the subsequent process (Appendix H) (Stecker et al., 2009). The 
patient will be required to inform the physician who performed the procedure or their 
referring doctor if skin changes occur within two weeks after the procedure. A 
scheduled follow-up examination with the referring physician will take place within 30 
days of the procedure. The follow-up will take place irrespective of whether any 
reddening of the skin has occurred and whether or not the patient has informed the 
doctor.  
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6.6  CONCLUSION 
 
Interventional fluoroscopic procedures are known for high doses, depending on a 
wide range of influencing factors. At the research site the doses of patients for 
vascular diagnostic and interventional procedures, although recorded, needed 
evaluation, and specific follow-up procedures are to be implemented. The purpose of 
this research project was to determine the dose ranges that can be expected for 
various procedures, taking into consideration all the major contributing factors 
influencing the patient’s dose. The relationship of technology, BMI of the patient and 
the practitioner’s level of experience to dose was evaluated. 
 
From the literature, DRLs for simple x-ray examinations, such as chest and 
abdominal x-rays, act as a guidance level of what the doses at an institution need to 
be under normal conditions. It was found that determining DRLs for dose-intensive 
procedures that involves fluoroscopy, such as interventional procedures, is difficult. 
There are a few factors that lead to a wide distribution of patient doses; the complex 
nature of the procedures, loose definition of the examination, various techniques and 
protocols being used, and dose dependence on the radiologist’s level of experience 
(Aroua et al., 2004) contribute to the wide distribution. A global concern is that 
interventional radiology is being performed more frequently and is becoming more 
complex, resulting in the risk of radiation injuries. Radiation protection and limiting or 
avoiding the occurrence of such effects are constantly being promoted and enforced 
by international and local governing organisations. 
 
During the three-year study period at the research site, useful data were collected for 
3 080 patients. When compared to documented international values, most locally 
performed procedures delivered lower or on par radiation doses; however, there 
were two isolated occurrences at the research site where the response threshold 
value for deterministic effects was exceeded. These two instances represent 0.06% 
of the total amount of useful data. When evaluating the 75th percentile values, it was 
seen that all of these values were significantly lower. This value is to be used when 
obtaining informed consent. Comparing doses to individual patients and the 
population the renal arteriogram, TFO, EVAR, four-vessel angiogram, ERCP and 
TBO were seen to be the procedures giving higher doses. 
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In evaluating the factors that influence the dose to the patient the following was 
concluded: 
 
E-room, although newly installed with flat-panel technology produced higher doses 
than in the vascular suite. Less procedure types were performed on fewer patients 
by fewer physicians than in the vascular suite. The BMI value of a patient, although a 
contributing factor, cannot be used as the only measure of expected dose. The 
registrars in the arterial outflow group as well as in the cerebral angiogram group 
delivered higher doses than the consultants and interventionists. 
 
This specific research study set out to determine dose ranges for procedures 
performed in the vascular laboratories of Universitas Hospital for diagnostic and 
interventional procedures to determine specific high dose procedures to the 
individual and population, and investigate the relationship of specific factors on dose. 
Has this been achieved? The large amount of documented data over the tree-year 
period was used to determine dose ranges for most common procedures. This 
information will definitely be used as a starting point for assessment of doses at local 
level. These data will be used as baseline values, and although the setting of DRLs 
was not intended, it can be seen that the 75th percentile values can be used, even if 
only for comparison purposes, to determine if further optimization actions are 
needed. If optimization of doses is needed, these 75th percentile values can give an 
indication as to which doses need to be optimized first. Investigation-specific factors 
showed an interdependent and intertwined relationship with the dose the patient is to 
receive. The specific dose optimising programme will be recommended for 
implementation at the research site. The programme will give clear instructions to all 
involved personnel, from the pre-procedural planning phase and intra-procedural 
dose management to the evaluating of the dose that the patient received and follow-
up procedure if necessary. The information from this study is a starting point for dose 
limitation and optimisation at the research site. The dose optimising and follow-up 
procedure proposed will ensure better informed clinicians, interventionists, 
radiographers and patients.  
 
From our experience, after doing the research and in our environment (the research 
site), it was seen that multiple procedure types were performed on a varied 
96 
composition of patients. These ranged from paediatric to adult and with varying 
BMIs, by practitioners with different levels of experience on different types of 
equipment. Considering all this information, it was seen that the majority of radiation 
doses at the research site was significantly lower than the response threshold values 
for deterministic effects. However, radiation doses always need some optimisation, 
as is evidenced by the two dose values breaching the 2 000 mGy threshold level for 
skin injuries and the possibility of stochastic effects. This should be achieved by 
implementing the proposed dose optimising programme, which will create greater 
awareness amongst all role-players, including the patient.  
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Poster of Pilot Study: Audit of Staff and Patient 
Doses in a General Vascular Laboratory 
Presented at the 26
th
 SAAPMB Congress 
 
 
 
 
 
 
 
 
 
 
 
  
 Appendix B 
 
Information Entered On Data Sheet 
 
 
 
 
 
 
 
 
 
 
 
  
 Information entered on the data sheet: 
 
Date of the procedure  
Procedure x-ray number indicated in procedure book 
UM number (unique identifier to the hospital) 
Procedure performed  
Diagnostic/Interventional procedure 
DAP reading (cGy.cm2/µGy.m2) 
Screening time (s) 
Doctor performing the procedure 
Classification: Registrar/Consultant/Interventionist 
Vascular Suite/E-room 
Error (if data are missing/incomplete) 
Height of the patient (m) 
Weight of the patient (kg) 
Body Mass Index (BMI) of the patient = (kg/m2) 
 
 
 
 
 
 
 
 
  
 Appendix C 
 
List of Procedures, Classifications of 
Diagnostic/Interventional and Field Area Sizes 
 
 
 
 
 
 
 
 
 
 
  
 NO PROCEDURE Diagnostic(1)/Interventional(2) 
Field 
Area 
(cm²) 
1 Oesophagus Dilatation Int (2) 20x20 
2 PTC/Percutaneous Gastr Int (2) 28x28 
3 Four Vessel Angiogram Diag (1) 28x28 
4 PTC Follow-up Int (2) 28x28 
5 Perm Cath Int (2) 28x28 
6 ERCP Int (2) 28x28 
7 TFO/Limb arm/leg Diag (1) 40x40 
8 Aorta Angiogram Diag (1) 40x40 
9 Bronchial Artery  Embolization Int (2) 40x40 
10 Chemo Embolization/ARF/TACE Int (2) 28x28 
11 Embolization AVM Int (2) 28x28 
12 Nephrostogram/Nephrostomy Int (2) 28x28 
13 Splenoportogram Diag (1) 28x28 
14 Sino gram Diag (1) 28x28 
15 PL Tube/Oesophagus stent Int (2) 28x28 
16 IVC Filter Int (2) 20x20 
17 
Fine needle Aspiration/Drainage 
(Abscess) Int (2) 20x20 
18 TBO Diag (1) 40x40 
19 Renal Arteriogram Diag (1) 20x20 
20 Pelvis Arteriogram Diag (1) 40x40 
21 Carotid Arteriogram Diag (1) 20x20 
22 Arteriogram of the face Diag (1) 20x20 
23 Perm Catheter Brush Int (2) 20x20 
24 Six Vessel Angiogram Diag (1) 28x28 
25 Percutaneous Kidney Stone Removal Int (2) 20x20 
26 
Removal of Pancreas tube/Carey 
Coons stent Int (2) 40x40 
27 
Placing of Naso-duodenal 
tube/Feeding tube Int (2) 20x20 
28 Embolization Varico cele Int (2) 20x20 
29 IVC Gram Diag (1) 40x40 
30 Angioplasty leg/arm/renal Int (2) 20x20 
31 
Hickman line/Revision line/Chemo 
Port Int (2) 20x20 
32 JJ catheter/Ante grade  Int (2) 20x20 
33 Venogram Diag (1) 40x40 
34 Fistulogram/Fistulogram arm Diag (1) 20x20 
35 EVAR Int (2) 28x28 
36 Iliac stent/TFO & stent/Stent Femur Int (2) 28x28 
37 
Occlusion Balloon Aneurism 
(subclavian) Int (2) 20x20 
38 Stent Carotid/Occlusion Carotid Int (2) 20x20 
39 
Embolization Face 
(Haemangioma)/Nasopharynx 
angiofibroma/Hem back/parotid Int (2) 20x20 
40 Hepatic/Splenic Artery Embolization Int (2) 40x40 
41 Foreign Body Removal Int (2) 28x28 
42 Stent AV Fistula (subclavian) Int (2) 20x20 
43 Pressure Trans-femoral /Aorta/IVC Diag (1) 40x40 
 44 Duodenal dilatation/stent/Colon stent Int (2) 28x28 
45 Drainage cyst kidney/ Follow-up Int (2) 28x28 
46 Arteriogram Spinal Diag (1) 40x40 
47 
Sheath and catheter  placing 
Brachial/Placing thrombolysis 
catheter Int (2) 40x40 
48 
Embolization Fistula/Carotid/Dural 
fistula Int (2) 28x28 
49 
Fine needle biopsy of para spinal 
tumour Diag (1) 28x28 
50 Streptokinase Follow-up Diag (1) 40x40 
51 
Bronchial Arteriogram/ Pulmonary 
Arteriogram Diag (1) 40x40 
52 Embolization Forearm/lower leg Int (2) 40x40 
53 Cholecystostomy Diag (1) 28x28 
54 UAE Int (2) 28x28 
55 Embolization Aneurysm Int (2) 28x28 
56 Embolization Kidney/Renal Int (2) 28x28 
57 Lumbar Puncture under Fluoroscopy Diag (1) 28x28 
58 Selective Arteriogram Diag (1) 40x40 
59 Two Vessel Angiogram Diag (1) 28x28 
60 Fine Needle Aspiration Int (2) 28x28 
61 
Abscess Drainage/Fluid 
collection/Percutaneous drainage Int (2) 28x28 
62 Replace Drainage catheter Int (2) 28x28 
63 Removal of Stent/Nephrostomy tube Int (2) 40x40 
64 Bronchial Stent Int (2) 28x28 
65 Stent Renal Int (2) 28x28 
66 Intussusception Reduction Int (2) 28x28 
67 
Embolization nose bleed/Abdominal  
bleed Int (2) 20x20 
68 Port Block Int (2) 28x28 
69 Embolization Rectum/Pelvis Int (2) 28x28 
70 Rectum Stent Int (2) 28x28 
71 Venous Sampling Diag (1) 28x28 
72 Renin Levels Diag (1) 28x28 
73 Revise AV Fistula Int (2) 20x20 
74 Lumbar Artery embolization Int (2) 28x28 
75 Embolization Flank Int (2) 28x28 
76 
Embolization mamma 
artery/subclavian Int (2) 28x28 
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Ethical Committee Approval for the Research 
Study 
 
 
 
 
 
 
 
 
 
 
 
  
 Appendix E 
 
Approval for study Universitas Hospital Head: 
Clinical Services 
 
 
 
 
 
 
 
 
 
 
 
  
 Appendix F 
 
Approval for study Universitas Hospital Radiation 
Control Committee 
 
 
 
 
 
 
 
 
 
 
 
  
 Appendix G 
 
Patient Consent to be weighed and measured 
 
 
 
 
 
 
 
 
 
 
 
  
 Appendix H 
 
Post procedural patient information leaflet 
 
 
 
 
 
 
 
 
 
 
 
 Information Leaflet for Patient Follow-up: 
 
 
Patient Name:      Date: 
 
At the completion of your diagnostic and/or interventional procedure it was found 
that: 
 
During your procedure you did not receive a significant amount of radiation (x-
rays).  No specific follow-up will be required because radiation side effects are 
highly unlikely.  
 
During your procedure you received a significant amount of radiation (x-rays).  
Radiation side-effects are unlikely but possible.  Please check your skin in the     
       area for any sign of reddening or itching in two 
weeks’ time or  
Please call the X-ray department at (###) ### ####, to report if there is any 
sign of reddening of your skin to dr.      . 
You are required to come and see dr.       again on  
 . 
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Abstracts of poster and paper presentations 
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(Paper Presentation) 
Faculty of Health 
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University of the Free 
State (UFS) 
23-24 
August 
2007 
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PROCEDURES AT UNIVERSITAS 
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(Paper Presentation) 
Faculty of Health 
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University of the Free 
State (UFS) 
23  
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2012 
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International Society of 
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th
 World Congress 
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2014 
 
 
